Use this section to confirm heading fidelity, spot spacing artifacts, inspect first-class table content, and
understand how nearby paragraphs and tables were sequenced during parsing. Matched in-text citations now jump to
their reference entries, while unresolved citations route to open citation issues.
paragraph
Order 1
Style Comment
word/document.xml:/w:document[1]/w:body[1]/w:p[1]
Use this form to tell us important information about this document, then start the text on the following page. All information you give in this form will appear in the document, or affect the way it is handled online
paragraph
Order 3
Style Comment
word/document.xml:/w:document[1]/w:body[1]/w:p[2]
Note: for “Document type,” choose only one of the following: appendix, chapter, dedication, foreword, front-matter-part, glossary, preface, ref-list, or section.
paragraph
Order 8
word/document.xml:/w:document[1]/w:body[1]/w:p[6]
Blank or “Yes” is the default value, indicating these features will apply to the document.
paragraph
Order 10
word/document.xml:/w:document[1]/w:body[1]/w:p[7]
Use one row for each author. List authors in order of appearance in the document. Add rows to add more authors. For institutional author, enter the name of the institution in the Given Name(s) column.
heading
Order 13
Level 1
Style Heading1
word/document.xml:/w:document[1]/w:body[1]/w:p[9]
heading
Order 16
Level 2
Style Heading2
word/document.xml:/w:document[1]/w:body[1]/w:p[12]
heading
Order 17
Level 3
Style Heading3
word/document.xml:/w:document[1]/w:body[1]/w:p[13]
paragraph
Order 18
Style Processinginstruction
word/document.xml:/w:document[1]/w:body[1]/w:p[14]
paragraph
Order 19
word/document.xml:/w:document[1]/w:body[1]/w:p[15]
Minocycline is a tetracycline antibiotic with excellent absorption and tissue penetration that is used for several bacterial infections as well as treatment of acne. Minocycline can cause both an acute hepatitis-like syndrome occurring within 1 to 3 months of starting therapy or a more insidious chronic hepatitis with autoimmune features typically after long term treatment.
heading
Order 21
Level 3
Style Heading3
word/document.xml:/w:document[1]/w:body[1]/w:p[17]
paragraph
Order 22
word/document.xml:/w:document[1]/w:body[1]/w:p[18]
Minocycline (min" oh sye' kleen) is a semisynthetic derivative of tetracycline that has excellent oral absorption and wide tissue penetration. Like other tetracyclines, minocycline is believed to act by binding to bacterial ribosomes and inhibiting protein synthesis. Minocycline has a broad spectrum of activity against both gram positive and gram negative organisms. Minocycline was approved for use in the United States in 1971 and it continues in wide use, although recently at decreasing rates. Current indications are for therapy of susceptible infections, including gonorrhea, syphilis, non-gonococcal urethritis, Chlamydial infections, cholera, leprosy, and the meningococcal carrier state. The major use of minocycline, however, is for chronic treatment of acne and suppression of the staphylococcal bacterial flora that contribute to it. Minocycline is available in multiple generic forms as capsules or tablets of 50, 75 or 100 mg. For acute infections, minocycline is recommended in doses of 100 mg every 12 hours for 5 to 15 days, often after an initial loading dose of 200 mg. For therapy of acne, doses of 50 mg once to three times daily are recommended. Minocycline is also available in extended release formulations for daily dosing and as a solution or powder for intravenous use. Commercial names of minocycline include Minocin, Dynacin, Myrac, and Apo-, Novo- and PMS-Minocycline. Common side effects include nausea, diarrhea, gastrointestinal upset, headache, dizziness, visual blurring, skin rash and hypersensitivity reactions.
heading
Order 23
Level 3
Style Heading3
word/document.xml:/w:document[1]/w:body[1]/w:p[19]
paragraph
Order 24
word/document.xml:/w:document[1]/w:body[1]/w:p[20]
Minocycline therapy is associated with two forms of clinically apparent liver injury, an acute hepatitis-like syndrome that arises within 1 to 3 months of starting therapy and a chronic hepatitis-like syndrome typically with autoimmune features that occurs with long term therapy, sometimes after several years of use. There is some overlap between these two presentations of minocycline hepatotoxicity, both are associated with a hepatocellular pattern of serum enzyme elevations and both can be associated with autoantibodies and immunological features.
paragraph
Order 25
word/document.xml:/w:document[1]/w:body[1]/w:p[21]
Minocycline has been linked to cases of an acute hepatitis with jaundice that typically arises within a few weeks or months of starting therapy. The enzyme elevations are typically hepatocellular and resemble acute viral hepatitis. Immunoallergic features are common and may be prominent with fever, rash and eosinophilia and some cases with facial edema, lymphadenopathy and lymphocytosis that may resemble acute mononucleosis. The liver injury is usually self limited with complete resolution within 1 to 2 months of stopping. Some patients have autoimmune markers and these also improve upon stopping minocycline.
paragraph
Order 26
word/document.xml:/w:document[1]/w:body[1]/w:p[22]
Minocycline has also been linked to cases of chronic hepatitis with or without jaundice that typically arise during long term therapy, sometimes after years of use. The most common presentation is with an autoimmune hepatitis-like syndrome that can be severe and even fatal, particularly if minocycline is not stopped promptly. Patients can present acutely with jaundice and fatigue or chronically with insidious onset of fatigue, joint aches and jaundice, usually after 6 months to many years of therapy. A hepatocellular pattern of enzyme elevations is typical with ALT levels ranging from 3- to 20-fold elevated depending upon the severity and duration of the injury. Autoantibodies are usually present, typically antinuclear antibody (ANA) at titers of >1:160. In some cases, ANA may initially be negative, arising later as the disease progresses or starts to improve. Immunoglobulins are also usually elevated and liver biopsy demonstrates changes typical of autoimmune hepatitis with active interface hepatitis, spotty eosinophilic necrosis and portal infiltrates rich in lymphocytes and plasma cells. Fibrosis is uncommon, but can occur, particularly if the disease is prolonged and minocycline continued in the face of hepatic injury. The condition will resolve spontaneously if minocycline is withdrawn, but corticosteroids are often used. In long term follow up after stopping minocycline, chronic injury is rare, if it occurs at all and generally all symptoms and laboratory test abnormalities resolve within 6 to 12 months of stopping, although patients may continue to have low titers of ANA.
paragraph
Order 27
word/document.xml:/w:document[1]/w:body[1]/w:p[23]
Other immunologically mediated syndromes associated with minocycline use include a serum sickness like syndrome (generally within 3 to 12 weeks of starting), a lupus-like syndrome and hemolytic anemia (the latter two with chronic therapy). Liver injury can accompany these other autoimmune conditions, but is generally anicteric, mild and rapidly reversible. The pattern of serum enzyme elevations is typically hepatocellular and autoantibodies are common.
paragraph
Order 28
word/document.xml:/w:document[1]/w:body[1]/w:p[24]
Likelihood score: A (well known cause of clinically apparent liver injury).
heading
Order 30
Level 3
Style Heading3
word/document.xml:/w:document[1]/w:body[1]/w:p[26]
paragraph
Order 31
word/document.xml:/w:document[1]/w:body[1]/w:p[27]
The cause of the liver injury associated with minocycline use is probably immunological, mediated by autoimmune reactions against liver cells or minocycline adducts present in the liver. Patients with minocycline induced liver injury have been reported to have an increased frequency of the rare HLA alelle B*35:02, but most cases lack this allele and clinical features are not different in those with or without the HLA association.
heading
Order 33
Level 3
Style Heading3
word/document.xml:/w:document[1]/w:body[1]/w:p[29]
H3. Outcome and Management
paragraph
Order 34
word/document.xml:/w:document[1]/w:body[1]/w:p[30]
The acute liver injury attributed to minocycline is usually self-limited in course, although fatal examples have been reported. In addition, the autoimmune hepatitis like syndrome caused by minocycline can be severe, and fatal outcomes have been described. Most cases, however, resolve slowly with withdrawal of the agent. Corticosteroids are often used to treat minocycline induced liver injury, largely because it resembles spontaneous autoimmune hepatitis and responds rapidly to immunosuppressive therapy. The effectiveness of corticosteroids in speeding or ensuring recovery from minocycline induced autoimmune hepatitis has not been proven, but anecdotal cases suggest a fairly dramatic effect. If corticosteroids are used, the dose should be rapidly reduced and discontinued within 3 to 6 months. Furthermore, patients should be followed carefully after withdrawal of corticosteroids. Recurrence of hepatitis after withdrawal should suggest that the autoimmune hepatitis was unrelated to the minocycline or that the minocycline brought out the autoimmune diathesis that is self-sustaining. Autoimmune hepatitis not caused by medications usually requires long term if not life long immunosuppressive therapy. There is no information about possible cross sensitivity to hepatic injury among the various tetracyclines. Interestingly, doxycycline which resembles minocycline structurally, has been associated with a short latency acute cholestatic or mixed hepatitis with immunoallergic features, but has not been associated definitively with the longer latency autoimmune hepatitis-like syndrome.
paragraph
Order 35
word/document.xml:/w:document[1]/w:body[1]/w:p[31]
heading
Order 37
Level 2
Style Heading2
word/document.xml:/w:document[1]/w:body[1]/w:p[33]
heading
Order 38
Level 3
Style Heading3
word/document.xml:/w:document[1]/w:body[1]/w:p[34]
H3. Case 1. Chronic hepatitis with autoimmune features caused by minocycline.(1)
paragraph
Order 39
word/document.xml:/w:document[1]/w:body[1]/w:p[35]
A 20 year old woman had been taking minocycline for acne for one and a half years when she developed joint pains in the hands, wrists, hips and ankles. She stopped minocycline and began to feel better, but was found to have markedly elevated serum enzymes on routine evaluation of the joint symptoms a few weeks later. She denied significant past medical history and had no risk factors for viral hepatitis. She took no other medications except oral contraceptives and did not drink alcohol regularly. Initially, serum ALT and AST were 15- to 20-fold elevated, but alkaline phosphatase and serum bilirubin were normal. Tests for hepatitis A, B, and C and for infectious mononucleosis were negative. Autoantibody testing showed a positive antinuclear antibody (1:160), but negative tests for smooth muscle and liver-kidney microsomal antibodies. Serum globulins were elevated as was IgG (1960 mg/dL, normal <1520). Ceruloplasmin was low normal. An ultrasound of the abdomen showed normal gallbladder and no enlargement of bile ducts. A liver biopsy showed changes suggestive of autoimmune hepatitis with marked interface hepatitis, portal inflammation with lymphocytes and plasma cells, but no fibrosis. She was started on prednisone and laboratory test abnormalities improved rapidly.
heading
Order 41
Level 4
Style Heading4
word/document.xml:/w:document[1]/w:body[1]/w:p[37]
table
Order 43
word/document.xml:/w:document[1]/w:body[1]/w:tbl[4]
Table.
Medication: | Minocycline (100 mg daily) |
Pattern: | Hepatocellular (elevations in ALT only) |
Severity: | 1+ (no jaundice) |
Latency: | 1.5 years |
Recovery: | 8 months on prednisone |
Other medications: | Oral contraceptives, rare use of ibuprofen |
Table footprint: 6 rows, 12 cells
heading
Order 46
Level 4
Style Heading4
word/document.xml:/w:document[1]/w:body[1]/w:p[41]
table
Order 48
word/document.xml:/w:document[1]/w:body[1]/w:tbl[5]
Table.
Time After Starting | Time After Stopping | ALT (U/L) | Alk P (U/L) | Bilirubin (mg/dL) | Other |
1.5 years | 1 month | 607 | 87 | 0.2 | |
| 1.5 months | 965 | 86 | 0.4 | |
2.2 years | 9 months | 216 | 88 | 0.3 | Biopsy |
| 10 months | 135 | 90 | 0.4 | Prednisone started |
| 11 months | 41 | 55 | 0.3 | |
2.5 years | 12 months | 27 | .. | 0.3 | |
| 15 months | 55 | 57 | .. | Prednisone stopped |
3 years | 18 months | 45 | 62 | 0.3 | |
4 years | 30 months | 23 | | Normal | |
Normal Values | <35 | <130 | <1.2 | |
Table footprint: 11 rows, 65 cells
heading
Order 51
Level 4
Style Heading4
word/document.xml:/w:document[1]/w:body[1]/w:p[45]
paragraph
Order 52
word/document.xml:/w:document[1]/w:body[1]/w:p[46]
The major symptoms were arthralgias, suggesting that the reaction to minocycline therapy was a lupus-like syndrome. These symptoms, however, abated and the patient was found to have a fairly significant anicteric hepatitis which was slow to resolve. Ultimately, a liver biopsy was done that suggested autoimmune hepatitis. Thereupon, prednisone was started with prompt improvement in serum aminotransferase levels. The dose of prednisone was gradually decreased and stopped within 6 months. She had no further symptoms, but serum ALT levels were intermittently abnormal.
heading
Order 54
Level 3
Style Heading3
word/document.xml:/w:document[1]/w:body[1]/w:p[48]
H3. Case 2. Severe acute hepatitis with autoimmune features caused by minocycline.(1)
paragraph
Order 55
word/document.xml:/w:document[1]/w:body[1]/w:p[49]
A 21 year old man was started on minocycline for acne and two months later developed fatigue, dark urine, and weight loss and stopped therapy. A week later, he was admitted to the hospital because of jaundice. He denied a history of liver disease and risk factors for viral hepatitis. He drank alcohol rarely. Serum bilirubin was elevated as were serum aminotransferase levels. Tests for hepatitis A, B, and C and for infectious mononucleosis were negative. Autoantibody testing showed a positive antinuclear antibody (1:1280), but negative tests for smooth muscle and liver-kidney microsomal antibodies. A liver biopsy was done which showed changes suggestive of autoimmune hepatitis with marked activity. He was started on prednisone and rapidly improved. Therapy was gradually reduced and then discontinued several months later, without relapse of symptoms or recurrence of laboratory abnormalities.
heading
Order 57
Level 4
Style Heading4
word/document.xml:/w:document[1]/w:body[1]/w:p[51]
table
Order 59
word/document.xml:/w:document[1]/w:body[1]/w:tbl[6]
Table.
Medication: | Minocycline (100 mg daily for 9 weeks) |
Pattern: | Hepatocellular (elevations in ALT only) |
Severity: | 3+ (jaundice and hospitalization) |
Latency: | 8 weeks |
Recovery: | 2 months on prednisone |
Other medications: | None |
Table footprint: 6 rows, 12 cells
heading
Order 62
Level 4
Style Heading4
word/document.xml:/w:document[1]/w:body[1]/w:p[55]
table
Order 64
word/document.xml:/w:document[1]/w:body[1]/w:tbl[7]
Table.
Time After Starting | Time After Stopping | ALT (U/L) | Alk P (U/L) | Bilirubin (mg/dL) | Other |
10 weeks | 1 week | 1343 | 783 | 5.7 | |
11 weeks | 2 weeks | 1649 | 638 | 4.8 | Liver biopsy |
Prednisone (60 mg daily) started |
14 weeks | 5 weeks | 83 | 145 | 1.1 | |
Normal Values | <35 | <130 | <1.2 | |
Table footprint: 6 rows, 30 cells
heading
Order 67
Level 4
Style Heading4
word/document.xml:/w:document[1]/w:body[1]/w:p[59]
paragraph
Order 68
word/document.xml:/w:document[1]/w:body[1]/w:p[60]
Minocycline can cause either an acute or a chronic hepatitis, but both are characterized by a hepatocellular pattern of serum enzyme elevations, the presence of autoantibodies and a liver biopsy showing changes that resemble autoimmune hepatitis. Spontaneous recovery with stopping minocycline is the rule, but recovery can be prolonged, and prednisone therapy may speed the process. Whether prednisone actually improves ultimate outcome has not been proven. Nevertheless, both drug induced and spontaneous autoimmune hepatitis can be severe and even fatal, and prednisone therapy may provide rapid relief. Most important, however, is to limit the dose and duration of therapy, carefully monitoring patients after stopping for evidence of recurrence.
heading
Order 70
Level 2
Style Heading2
word/document.xml:/w:document[1]/w:body[1]/w:p[62]
paragraph
Order 71
word/document.xml:/w:document[1]/w:body[1]/w:p[63]
REPRESENTATIVE TRADE NAMES
paragraph
Order 72
word/document.xml:/w:document[1]/w:body[1]/w:p[64]
Minocycline – Generic, Dynacin®, Minocin®
paragraph
Order 73
word/document.xml:/w:document[1]/w:body[1]/w:p[65]
paragraph
Order 74
word/document.xml:/w:document[1]/w:body[1]/w:p[66]
paragraph
Order 75
word/document.xml:/w:document[1]/w:body[1]/w:p[67]
paragraph
Order 76
word/document.xml:/w:document[1]/w:body[1]/w:p[68]
Product labeling at DailyMed, National Library of Medicine, NIH
heading
Order 78
Level 2
Style Heading2
word/document.xml:/w:document[1]/w:body[1]/w:p[70]
H2. CHEMICAL FORMULAS AND STRUCTURES
table
Order 80
word/document.xml:/w:document[1]/w:body[1]/w:tbl[8]
Table.
DRUG | CAS REGISTRY NO | MOLECULAR FORMULA | STRUCTURE |
Minocycline Hydrochloride | 13614-98-7 | C23-H27-N3-O7.Cl-H | SID: 135017464 |
Doxycycline Monohydrate | 17086-28-1 | C22-H24-N2-O8.H2-O | SID: 135017344 |
Table footprint: 3 rows, 12 cells
heading
Order 83
Level 2
Style Heading2
word/document.xml:/w:document[1]/w:body[1]/w:p[74]
reference
Order 84
Style Reference
word/document.xml:/w:document[1]/w:body[1]/w:p[75]
1. de Boer YS, Kosinski AS, Urban TJ, Zhao Z, Long N, Chalasani N, Kleiner DE, Hoofnagle JH; Drug-Induced Liver Injury Network. Features of autoimmune hepatitis in patients with drug-induced liver injury. Clin Gastroenterol Hepatol 2017; 15: 103-12. 27311619
heading
Order 86
Level 2
Style Heading2
word/document.xml:/w:document[1]/w:body[1]/w:p[77]
H2. ANNOTATED BIBLIOGRAPHY
reference
Order 87
word/document.xml:/w:document[1]/w:body[1]/w:p[78]
References updated: 15 March 2026
reference
Order 88
Style Suggestedreading
word/document.xml:/w:document[1]/w:body[1]/w:p[79]
Zimmerman HJ. Tetracyclines. In, Zimmerman HJ. Hepatotoxicity: the adverse effects of drugs and other chemicals on the liver. 2nd ed. Philadelphia: Lippincott, 1999. p. 599-602.
reference
Order 89
Style Reference-annotation
word/document.xml:/w:document[1]/w:body[1]/w:p[80]
(Expert review of tetracycline and liver injury published in 1999; the tetracyclines cause two forms of drug induced liver injury, microvesicular fat and liver failure occurring after 4-10 days with high doses of parenteral tetracyclines and an idiosyncratic liver injury that occurs with the oral agents, doxycycline causing a cholestatic and minocycline a hepatocellular injury which may be associated with autoimmune features).
reference
Order 90
Style Suggestedreading
word/document.xml:/w:document[1]/w:body[1]/w:p[81]
Moseley RH. Tetracyclines. Hepatotoxicity of antimicrobials and antifungal agents. In, Kaplowitz N, DeLeve LD, eds. Drug-induced liver disease. 3rd ed. Amsterdam: Elsevier, 2013, p. 468.
reference
Order 91
Style Reference-annotation
word/document.xml:/w:document[1]/w:body[1]/w:p[82]
(Expert review of tetracycline induced liver injury mentions that the hepatotoxicity of intravenous tetracycline is of historic interest only as it is no longer given parenterally; both doxycycline and minocycline have been associated with idiosyncratic liver injury).
reference
Order 92
Style Suggestedreading
word/document.xml:/w:document[1]/w:body[1]/w:p[83]
MacDougall C, Chambers HF. Tetracyclines and glycylcyclines. Protein synthesis inhibitors and miscellaneous antibacterial agents. In, Brunton LL, Chabner KA, Knollman KC, eds. Goodman & Gilman’s the pharmacological basis of therapeutics. 12th ed. New York: McGraw-Hill, 2011, pp. 1521-6.
reference
Order 93
Style Reference-annotation
word/document.xml:/w:document[1]/w:body[1]/w:p[84]
(Textbook of pharmacology and therapeutics).
reference
Order 94
Style Suggestedreading
word/document.xml:/w:document[1]/w:body[1]/w:p[85]
Schultz JC, Adamson JS Jr, Workman WW, Norman TD. Fatal liver disease after intravenous administration of tetracycline in high dosage. N Engl J Med 1963; 269: 999-1004. PMID: 14059734
reference
Order 95
Style Reference-annotation
word/document.xml:/w:document[1]/w:body[1]/w:p[86]
(Initial dramatic report of acute fatty liver due to iv tetracycline; a rapidly fatal multisystem disease appeared in 6 pregnant women in their last trimester or early postpartum period after 3 to 5 days of relatively high doses of iv tetracycline; all developed jaundice [bilirubin 4.9-12.5 mg/dL] with mild AST [72-170 U/L] and Alk P [9-17 King Armstrong U/L] elevations, prolongation of protime, acidosis and renal dysfunction. Autopsy showed foamy hepatocytes, fat by oil red O stain and minimal hepatocyte necrosis).
reference
Order 96
Style Suggestedreading
word/document.xml:/w:document[1]/w:body[1]/w:p[87]
Dowling HF, Lepper MH. Hepatic reactions to tetracycline. JAMA 1964; 188: 307-9. PMID: 14114004
reference
Order 97
Style Reference-annotation
word/document.xml:/w:document[1]/w:body[1]/w:p[88]
(Review of literature on acute fatty liver due to tetracycline and recommendations on its use: avoiding doses >2 g/day and cautious use in women in last trimester of pregnancy).
reference
Order 98
Style Suggestedreading
word/document.xml:/w:document[1]/w:body[1]/w:p[89]
Horwitz ST, Marymont JH Jr. Fatal liver disease during pregnancy associated with tetracycline therapy. Report of a case. Obstet Gynecol 1964; 23: 826-9. PMID: 14168241
reference
Order 99
Style Reference-annotation
word/document.xml:/w:document[1]/w:body[1]/w:p[90]
(After complicated Caesarian and emergency hysterectomy with shock and bleeding, 41 year old woman received tetracycline given iv for 4 days, then orally to day 8; on day 10 she developed fever, acidosis and ileus, dying on day 16 with multiorgan failure and jaundice; autopsy showed fatty liver).
reference
Order 100
Style Suggestedreading
word/document.xml:/w:document[1]/w:body[1]/w:p[91]
Norman TD, Schultz JC, Hoke RD. Fatal liver disease following the administration of tetracycline. South Med J 1964; 57: 1038-42. PMID: 14179316
reference
Order 101
Style Reference-annotation
word/document.xml:/w:document[1]/w:body[1]/w:p[92]
(Further analysis of 6 cases of acute fatty liver after tetracycline in pregnant women with histological changes).
reference
Order 102
Style Suggestedreading
word/document.xml:/w:document[1]/w:body[1]/w:p[93]
Whalley PJ, Adams RH, Combes B. Tetracycline toxicity in pregnancy. Liver and pancreatic dysfunction. JAMA 1964; 189: 357-62. PMID: 14160508
reference
Order 103
Style Reference-annotation
word/document.xml:/w:document[1]/w:body[1]/w:p[94]
(Five cases of acute fatty liver with azotemia and pancreatitis after 4-17 days of iv or oral therapy 1-2 g/day: bilirubin 1.2-18.8 mg/dL; AST 34-780 U/L; Alk P 8.6-22 BU/L; 1 case fatal. The anicteric case had pancreatitis and was attributed to oral drug but had fat on liver biopsy).
reference
Order 104
Style Suggestedreading
word/document.xml:/w:document[1]/w:body[1]/w:p[95]
Brewer T. Tetracycline hepatotoxicity. Br Med J 1965; 1: 995. PMID: 14260641
reference
Order 105
Style Reference-annotation
word/document.xml:/w:document[1]/w:body[1]/w:p[96]
(Letter questioning role of tetracycline in acute fatty liver).
reference
Order 106
Style Suggestedreading
word/document.xml:/w:document[1]/w:body[1]/w:p[97]
Finn WF, Horwitz ST. Maternal death due to fatty metamorphosis of liver following tetracycline therapy. N Y State J Med 1965; 65: 662-7. PMID: 14251580
reference
Order 107
Style Reference-annotation
word/document.xml:/w:document[1]/w:body[1]/w:p[98]
(After Caesarian section, followed by hysterectomy and pneumonia, 41 year old woman received iv tetracycline for 4 days, followed by oral and then iv drug again, developing shock and jaundice; autopsy showed fatty liver without necrosis).
reference
Order 108
Style Suggestedreading
word/document.xml:/w:document[1]/w:body[1]/w:p[99]
Ichida F, Watanabe K, Ishiwara S, Inoue K, Tanabe Y. [A case of cholestatic jaundice due to tetracycline-triacetyloleandomycin] Nippon Naika Gakkai Zasshi 1965; 54:142-7. Japanese. PMID: 5294320
reference
Order 110
Style Suggestedreading
word/document.xml:/w:document[1]/w:body[1]/w:p[101]
Kunelis CT, Peters JL, Edmondson HA. Fatty liver of pregnancy and its relationship to tetracycline therapy. Am J Med 1965; 38: 359-77. PMID: 14266828
reference
Order 111
Style Reference-annotation
word/document.xml:/w:document[1]/w:body[1]/w:p[102]
(Classical clinical and histologic description of syndrome in 12 pregnant women, ages 19-31, given tetracycline for 3 to 12 days [total dose 1.5 to 14 g] after 16-39 weeks of pregnancy [bilirubin 12-19.8 mg/dL, ALT 24-210 U/L, AST 36-760 U/L, lactic acid high in 3/3 patients], 67% fatal, often accompanied by multiorgan failure, pancreatitis and shock).
reference
Order 112
Style Suggestedreading
word/document.xml:/w:document[1]/w:body[1]/w:p[103]
Tapp E, Carroll R. Tetracycline accumulation in toxic liver damage. J Pathol Bacteriol 1965; 89: 715-21. PMID: 14320315
reference
Order 113
Style Reference-annotation
word/document.xml:/w:document[1]/w:body[1]/w:p[104]
(Animal studies showing accumulation of tetracycline in damaged hepatocytes, particularly with high levels of calcium).
reference
Order 114
Style Suggestedreading
word/document.xml:/w:document[1]/w:body[1]/w:p[105]
Winterling AN, Goldman RL. Hepatic and renal lesions in a case of tetracycline toxicity during long-term estrogen therapy after orchiectomy. Calif Med 1965; 102: 314-6. PMID: 14291456
reference
Order 115
Style Reference-annotation
word/document.xml:/w:document[1]/w:body[1]/w:p[106]
(66 year old man post-orchiectomy for prostate cancer developed sudden onset of fever, lactic acidosis and mild jaundice [bilirubin 2.9 mg/dL] after 8 days of iv tetracycline [17 g], subsequently died after emergency laparotomy; autopsy showed fatty liver).
reference
Order 116
Style Suggestedreading
word/document.xml:/w:document[1]/w:body[1]/w:p[107]
Wruble LD, Ladman AJ, Britt LG, Cummins AJ. Hepatotoxicity produced by tetracycline overdosage. JAMA 1965; 192: 6-8. PMID: 14262279
reference
Order 117
Style Reference-annotation
word/document.xml:/w:document[1]/w:body[1]/w:p[108]
(56 year old woman with cecal volvulus developed jaundice [bilirubin 7.8 mg/dL, AST 98 U/L, Alk P normal] 2 days after receiving 8 g of tetracycline, subsequently progressing to liver failure and death; autopsy showed fatty liver).
reference
Order 118
Style Suggestedreading
word/document.xml:/w:document[1]/w:body[1]/w:p[109]
Wruble LD, Cummins AJ. Tetracycline and fatty liver. Am J Dig Dis 1965; 10: 742-4. PMID: 14316764
reference
Order 119
Style Reference-annotation
word/document.xml:/w:document[1]/w:body[1]/w:p[110]
(Editorial on tetracycline induced acute fatty liver with discussion of mechanisms focusing on mitochondrial injury).
reference
Order 120
Style Suggestedreading
word/document.xml:/w:document[1]/w:body[1]/w:p[111]
Tetracyclines and the liver in pregnancy. Lancet 1966; 1: 357-8. PMID: 4159865
reference
Order 121
Style Reference-annotation
word/document.xml:/w:document[1]/w:body[1]/w:p[112]
(Editorial on the history of acute fatty liver of pregnancy, first described by Sheehan in 1940 and later linked to high dose iv tetracycline in pregnancy, but also in nonpregnant women and in men).
reference
Order 122
Style Suggestedreading
word/document.xml:/w:document[1]/w:body[1]/w:p[113]
Davis JS, Kaufman RH. Tetracycline toxicity. A clinicopathologic study with special reference to liver damage and its relationship to pregnancy. Am J Obstet Gynecol 1966; 95: 523-9. PMID: 5939019
reference
Order 123
Style Reference-annotation
word/document.xml:/w:document[1]/w:body[1]/w:p[114]
(Six cases of acute fatty liver, 1 man and 5 women [4 pregnant] given intravenous tetracycline for 9-10 days [3-6 g] [bilirubin 3-12.5 mg/dL, ALT 34-310 U/L], all acidotic and all died, autopsy showing fatty liver).
reference
Order 124
Style Suggestedreading
word/document.xml:/w:document[1]/w:body[1]/w:p[115]
Schiffer MA. Fatty liver associated with administration of tetracycline in pregnant and nonpregnant women. Am J Obstet Gynecol 1966; 96: 326-32. PMID: 5919490
reference
Order 125
Style Reference-annotation
word/document.xml:/w:document[1]/w:body[1]/w:p[116]
(Six cases of acute fatty liver from tetracycline, 2 in pregnancy at 34- and 40 weeks; 4 in nonpregnant women, but clinical course not described).
reference
Order 126
Style Suggestedreading
word/document.xml:/w:document[1]/w:body[1]/w:p[117]
Aach R, Kissane J eds. Clinicopathologic conference. A seventeen-year-old girl with fatty liver of pregnancy following tetracycline therapy. Am J Med 1967; 43: 274-83. PMID: 6034958
reference
Order 127
Style Reference-annotation
word/document.xml:/w:document[1]/w:body[1]/w:p[118]
(Clinicopathologic conference describing 17 year old pregnant woman who developed suspected pyelonephritis, was treated with im and oral tetracycline and 8 days later developed multiorgan failure, lactic acidosis and died despite induced delivery of a stillborn child).
reference
Order 128
Style Suggestedreading
word/document.xml:/w:document[1]/w:body[1]/w:p[119]
Peters RL, Edmondson HA, Mikkelsen WP, Tatter D. Tetracycline-induced fatty liver in nonpregnant patients. A report of six cases. Am J Surg 1967; 113: 622-32. PMID: 6021433
reference
Order 129
Style Reference-annotation
word/document.xml:/w:document[1]/w:body[1]/w:p[120]
(Classical description of clinical and histologic features of tetracycline induced acute fatty liver in nonpregnant patients; 6 nonpregnant women, ages 18-62, given iv tetracycline for 3-13 days [9-26 g] presenting with jaundice and lethargy; peak AST 52-960 U/L; bilirubin 2.7-7.4 mg/dL, often with complex and critical course, pancreatitis and renal failure, acidosis; fatty liver on autopsy).
reference
Order 130
Style Suggestedreading
word/document.xml:/w:document[1]/w:body[1]/w:p[121]
Damjanov I, Arnold R, Faour M. Tetracycline toxicity in a nonpregnant woman. JAMA 1968; 204: 934. PMID: 5694615
reference
Order 131
Style Reference-annotation
word/document.xml:/w:document[1]/w:body[1]/w:p[122]
(20 year old woman given iv tetracycline for 8 days after second of two gall bladder operations developed sudden onset of renal and hepatic failure [bilirubin 4.2 mg/dL, ALT 620 U/L], autopsy showed fatty liver and acute tubular necrosis).
reference
Order 132
Style Suggestedreading
word/document.xml:/w:document[1]/w:body[1]/w:p[123]
Robinson MJ, Rywlin AM. Tetracycline-associated fatty liver in the male. Report of an autopsied case. Am J Dig Dis 1970; 15: 857-62. PMID: 5459744
reference
Order 133
Style Reference-annotation
word/document.xml:/w:document[1]/w:body[1]/w:p[124]
(72 year old man given 10 days of iv tetracycline [30 g total] developed worsening liver injury followed by hepatic and renal failure and severe acidosis [bilirubin 6.8 mg/dL, AST 1550 KU/L, Alk P 15 KA U/L]; autopsy showed fatty liver, fatty vacuolization of renal tubular cells and pancreatitis).
reference
Order 134
Style Suggestedreading
word/document.xml:/w:document[1]/w:body[1]/w:p[125]
Breen KJ, Perkins KW, Mistilis SP, Shearman R. Idiopathic acute fatty liver of pregnancy. Gut 1970; 11: 822-5. PMID: 5485832
reference
Order 135
Style Reference-annotation
word/document.xml:/w:document[1]/w:body[1]/w:p[126]
(23 year old woman who survived acute fatty liver of pregnancy; onset day after spontaneous labor and stillborn delivery [bilirubin 7.9 mg/dL, Alk P 70 King Armstrong U/L, AST 67 U/L, prothrombin index 50%], liver biopsy showed fatty liver, improved with dextrose administration).
reference
Order 136
Style Suggestedreading
word/document.xml:/w:document[1]/w:body[1]/w:p[127]
Combes B, Whalley PJ, Adams RH. Tetracycline and the liver. Prog Liver Dis 1972; 4: 589-96. PMID: 4569011
reference
Order 137
Style Reference-annotation
word/document.xml:/w:document[1]/w:body[1]/w:p[128]
(Review of hepatotoxicity of tetracycline, including studies of pathogenesis).
reference
Order 138
Style Suggestedreading
word/document.xml:/w:document[1]/w:body[1]/w:p[129]
Wenk RE, Gebhardt FC, Bhagavan BS, Lustgarten JA, McCarthy EF. Tetracycline-associated fatty liver of pregnancy, including possible pregnancy risk after chronic dermatologic use of tetracycline. J Reprod Med 1981; 26: 135-41. PMID: 7230149
reference
Order 139
Style Reference-annotation
word/document.xml:/w:document[1]/w:body[1]/w:p[130]
(Two cases of acute fatty liver over a 15 year period and 60,000 deliveries; one woman received tetracycline for 3 days, the second had no history of its use, but had tetracycline detected in bony tissue suggestive of chronic use).
reference
Order 140
Style Suggestedreading
word/document.xml:/w:document[1]/w:body[1]/w:p[131]
Böcker R, Estler CJ, Müller S, Pfandzelter C, Spachmüller B. Comparative evaluation of the effects of tetracycline, rolitetracycline and doxycycline on some blood parameters related to liver function. Arzneimittelforschung 1982; 32: 237-41. PMID: 7200783
reference
Order 141
Style Reference-annotation
word/document.xml:/w:document[1]/w:body[1]/w:p[132]
(Minocycline caused a dose dependent rise in AST and increase in triglycerides, but no hepatic histological changes in mice; similar findings were previously reported with tetracycline).
reference
Order 142
Style Suggestedreading
word/document.xml:/w:document[1]/w:body[1]/w:p[133]
Burette A, Finet C, Prigogine T, De Roy G, Deltenre M. Acute hepatic injury associated with minocycline. Arch Intern Med 1984; 144: 1491-2. PMID: 6732411
reference
Order 143
Style Reference-annotation
word/document.xml:/w:document[1]/w:body[1]/w:p[134]
(57 year old woman developed jaundice after 4 days of iv minocycline for aspiration pneumonia: [bilirubin ~3.5 mg/dL, ALT 1050 U/L, Alk P 680 U/L, and high amylase], biopsy showed fatty liver with minimal inflammation).
reference
Order 144
Style Suggestedreading
word/document.xml:/w:document[1]/w:body[1]/w:p[135]
Schrumpf E, Nordgard K. Unusual cholestatic hepatotoxicity of doxycycline in a young male? Scand J Gastroenterol 1986; 21 (Suppl 120): 68. Not in PubMed
reference
Order 145
Style Reference-annotation
word/document.xml:/w:document[1]/w:body[1]/w:p[136]
(Abstract: Patient developed severe and prolonged cholestatic hepatitis after 2 weeks of oral doxycycline [bilirubin 9.8 rising to 69.5 mg/L, ALT 53 to 132 U/L, Alk P 283 to 775 U/L] and severe itching; ultimate recovery after 6 months).
reference
Order 146
Style Suggestedreading
word/document.xml:/w:document[1]/w:body[1]/w:p[137]
Davies MG, Kersey PJ. Acute hepatitis and exfoliative dermatitis associated with minocycline. BMJ 1989; 298: 1523-4. PMID: 2527068
reference
Order 147
Style Reference-annotation
word/document.xml:/w:document[1]/w:body[1]/w:p[138]
(16 year old boy and 17 year old girl developed severe hepatitis after 4 weeks of minocycline, both with severe skin rash [toxic epidermal necrolysis], fever, jaundice, lymphadenopathy and leukemoid reactions; one fatal, but history of travel to Africa and exposure to antimalarials).
reference
Order 148
Style Suggestedreading
word/document.xml:/w:document[1]/w:body[1]/w:p[139]
Adams LE, Hess EV. Drug-related lupus. Incidence, mechanisms and clinical implications. Drug Saf 1991; 6: 431-49. PMID: 1793523
reference
Order 149
Style Reference-annotation
word/document.xml:/w:document[1]/w:body[1]/w:p[140]
(Review of drug related lupus-like syndrome, linked to more than 60 agents including isoniazid, hydralazine, chlorpromazine, methyldopa and procainamide. Usually presents with arthralgias and fever and ANA positivity, usually occurring with long term use of the medication).
reference
Order 150
Style Suggestedreading
word/document.xml:/w:document[1]/w:body[1]/w:p[141]
Böcker R, Estler CJ, Ludewig-Sandig D. Evaluation of the hepatotoxic potential of minocycline. Antimicrob Agents Chemother 1991; 35: 1434-6. PMID: 1929305
reference
Order 151
Style Reference-annotation
word/document.xml:/w:document[1]/w:body[1]/w:p[142]
(High dose studies in rats showed rises in AST and hepatic triglycerides, but no changes in liver histology).
reference
Order 152
Style Suggestedreading
word/document.xml:/w:document[1]/w:body[1]/w:p[143]
Lienart F, Morissens M, Jacobs P, Ducobu J. Doxycycline and hepatotoxicity. Acta Clin Belg 1992; 47: 205-8. PMID: 1332350
reference
Order 153
Style Reference-annotation
word/document.xml:/w:document[1]/w:body[1]/w:p[144]
(42 year old woman with severe cardiomyopathy developed encephalopathy and enzyme elevations with jaundice after 5 days of oral doxycycline [bilirubin 1.2 mg/dL, ALT 139 U/L, Alk P 373 U/L, ammonia 99 mcg/dL], resolving rapidly on stopping; likely due to heart failure and ischemia rather than drug induced liver injury).
reference
Order 154
Style Suggestedreading
word/document.xml:/w:document[1]/w:body[1]/w:p[145]
Min DI, Burke PA, Lewis WD, Jenkins RL. Acute hepatic failure associated with oral minocycline: a case report. Pharmacotherapy 1992; 12: 68-71. PMID: 1532250
reference
Order 155
Style Reference-annotation
word/document.xml:/w:document[1]/w:body[1]/w:p[146]
(39 year old woman developed fatigue and nausea after 4 weeks of minocycline and vitamin A [50,000 U bid] followed by high fever, lymphadenopathy and jaundice progressing to acute liver failure [bilirubin rising from 0.9 to 23.5 mg/dL, ALT 120 to 1625 U/L, Alk P 892 U/L], ultimately resolving spontaneously after stopping).
reference
Order 156
Style Suggestedreading
word/document.xml:/w:document[1]/w:body[1]/w:p[147]
Boudreaux JP, Hayes DH, Mizrahi S, Hussey J, Regenstein F, Balart L. Fulminant hepatic failure, hepatorenal syndrome, and necrotizing pancreatitis after minocycline hepatotoxicity. Transplant Proc 1993; 25: 1873. PMID: 8470208
reference
Order 157
Style Reference-annotation
word/document.xml:/w:document[1]/w:body[1]/w:p[148]
(17 year old girl developed acute liver failure while taking minocycline, but no information given on dose, latency or laboratory abnormalities).
reference
Order 158
Style Suggestedreading
word/document.xml:/w:document[1]/w:body[1]/w:p[149]
Carson JL, Strom BL, Duff A, et al. Acute liver disease associated with erythromycins, sulfonamides, and tetracyclines. Ann Intern Med 1993; 119 (7 Pt 1): 576-83. PMID: 8363168
reference
Order 159
Style Reference-annotation
word/document.xml:/w:document[1]/w:body[1]/w:p[150]
(Case control study using Medicaid billing results between 1980-87 found 107 cases of hospitalization for unexplained hepatitis, odds ratios for erythromycin 5.2; sulfonamides 11.4; tetracyclines 5.2; total of 5 cases exposed to tetracycline, doxycycline or minocycline).
reference
Order 160
Style Suggestedreading
word/document.xml:/w:document[1]/w:body[1]/w:p[151]
Hunt CM, Washington K. Tetracycline-induced bile duct paucity and prolonged cholestasis. Gastroenterology 1994; 107: 1844-7. PMID: 7958700
reference
Order 161
Style Reference-annotation
word/document.xml:/w:document[1]/w:body[1]/w:p[152]
(Two cases of severe and prolonged cholestatic hepatitis and bile duct paucity after oral tetracyclines; 37 year old woman developed jaundice 2 days after 3 day course of doxycycline with prolonged cholestasis [peak bilirubin 30 mg/dL], but ultimate recovery; 63 year old woman developed jaundice 6 weeks after a 2 week course of tetracycline [bilirubin 11.8 mg/dL, ALT 245 U/L], with prolonged jaundice [peak bilirubin 29.5 mg/dL) and persistence of enzyme elevations for >3 years [Alk P 631 U/L, ALT 97 U/L]).
reference
Order 162
Style Suggestedreading
word/document.xml:/w:document[1]/w:body[1]/w:p[153]
Kaufmann D, Pichler W, Beer JH. Severe episode of high fever with rash, lymphadenopathy, neutropenia, and eosinophilia after minocycline therapy for acne. Arch Intern Med 1994; 154: 1983-4. PMID: 8074603
reference
Order 163
Style Reference-annotation
word/document.xml:/w:document[1]/w:body[1]/w:p[154]
(35 year old woman developed fever, rash and eosinophilia 3 weeks after starting minocycline for acne with normal ALT, AST and bilirubin and resolution in ~10 days of stopping, indicating a serum sickness-like syndrome without hepatitis).
reference
Order 164
Style Suggestedreading
word/document.xml:/w:document[1]/w:body[1]/w:p[155]
Friis H, Andreasen PB. Drug-induced hepatic injury: an analysis of 1100 cases reported to the Danish Committee on Adverse Drug Reactions between 1978 and 1987. J Intern Med 1992; 232: 133-8. PMID: 1506809
reference
Order 165
Style Reference-annotation
word/document.xml:/w:document[1]/w:body[1]/w:p[156]
(Adverse drug reaction reports between 1978 and 1987 in Denmark; no tetracycline is mentioned as a cause).
reference
Order 166
Style Suggestedreading
word/document.xml:/w:document[1]/w:body[1]/w:p[157]
Gordon PM, White MI, Herriot R, Martin JC, Reid DM. Minocycline-associated lupus erythematosus. Brit J Dermatol 1995; 132: 120-1. PMID: 7756122
reference
Order 167
Style Reference-annotation
word/document.xml:/w:document[1]/w:body[1]/w:p[158]
(15 year old girl developed arthralgias and lupus-like syndrome after 2 years of minocycline therapy of acne; liver tests were normal, ANA 1:640, resolved with stopping).
reference
Order 168
Style Suggestedreading
word/document.xml:/w:document[1]/w:body[1]/w:p[159]
Castex F, Canva-Delcambre V, Maunoury V, Talbodec N, Wolchies E, Paris JC. [Acute hepatitis induced by minocycline] Gastroenterol Clin Biol 1995; 19: 640-1. French. PMID: 7590035
reference
Order 169
Style Reference-annotation
word/document.xml:/w:document[1]/w:body[1]/w:p[160]
(30 year old woman developed jaundice 8 days after starting minocycline [bilirubin 2.0 mg/dL, ALT 23 times ULN, Alk P normal, ANA negative], with resolution of liver test abnormalities within 1 month of stopping).
reference
Order 170
Style Suggestedreading
word/document.xml:/w:document[1]/w:body[1]/w:p[161]
Gough A, Chapman S, Wagstaff K, Emery P, Elias E. Minocycline induced autoimmune hepatitis and systemic lupus erythematosus-like syndrome. BMJ 1996; 312: 169-72. PMID: 8563540
reference
Order 171
Style Reference-annotation
word/document.xml:/w:document[1]/w:body[1]/w:p[162]
(Brief report of 4 cases of jaundice developing during long term minocycline therapy and review of 16 cases reported to British Committee on Safety of Medicines; no specific laboratory results provided).
reference
Order 172
Style Suggestedreading
word/document.xml:/w:document[1]/w:body[1]/w:p[163]
Pillans PI. Drug associated hepatic reactions in New Zealand: 21 years’ experience. N Z Med J 1996; 109: 315-9. PMID: 8816722
reference
Order 173
Style Reference-annotation
word/document.xml:/w:document[1]/w:body[1]/w:p[164]
(Adverse drug reaction reports identified 943 liver injuries over 21 years in New Zealand; triacetyloleandomycin accounted for 21 cases [2.1%] and minocycline for at least 4).
reference
Order 174
Style Suggestedreading
word/document.xml:/w:document[1]/w:body[1]/w:p[165]
Goulden V, Glass D, Cunliffe WJ. Safety of long-term high-dose minocycline in the treatment of acne. Brit J Dermatol 1996; 134: 693-5. PMID: 8733373
reference
Order 175
Style Reference-annotation
word/document.xml:/w:document[1]/w:body[1]/w:p[166]
(Prospective study of safety of 100-200 mg minocycline given daily for average of 10 months, 200 of 700 patients who had liver tests done, there were “no significant abnormalities”).
reference
Order 176
Style Suggestedreading
word/document.xml:/w:document[1]/w:body[1]/w:p[167]
Knowles SR, Shapiro L, Shear NH. Serious adverse reactions induced by minocycline. Report of 13 patients and review of the literature. Arch Dermatol 1996; 132: 934-9. PMID: 8712844
reference
Order 177
Style Reference-annotation
word/document.xml:/w:document[1]/w:body[1]/w:p[168]
(15 cases with adverse reactions to minocycline; one with Stevens-Johnson syndrome and acute liver failure arising within 29 days of starting minocycline, necessitating liver transplantation).
reference
Order 178
Style Suggestedreading
word/document.xml:/w:document[1]/w:body[1]/w:p[169]
Malcolm A, Heap TR, Eckstein RP, Lunzer MR. Minocycline-induced liver injury. Am J Gastroenterol 1996; 91: 1641-3. PMID: 8759678
reference
Order 179
Style Reference-annotation
word/document.xml:/w:document[1]/w:body[1]/w:p[170]
(Three men and 3 women, ages 15-48, treated with minocycline for 4 weeks to 2 years developed liver injury [peak ALT 257 to 3824 U/L, 3 ANA positive, 3 with jaundice, most had mild eosinophilia], liver biopsy showed chronic hepatitis in 2, all recovered completely, two with corticosteroid therapy).
reference
Order 180
Style Suggestedreading
word/document.xml:/w:document[1]/w:body[1]/w:p[171]
Tham SN, Kwok YK, Chan HL. Cross-reactivity in fixed drug eruptions to tetracyclines. Arch Dermatol 1996; 132: 1134-5. PMID: 8795565
reference
Order 181
Style Reference-annotation
word/document.xml:/w:document[1]/w:body[1]/w:p[172]
(Among 9 Chinese patients with a fixed drug eruption due to tetracycline, all had recurrence on doxycycline and 3 on minocycline; no mention of liver involvement).
reference
Order 182
Style Suggestedreading
word/document.xml:/w:document[1]/w:body[1]/w:p[173]
MacNeil M, Haase DA, Tremaine R, Marrie TJ. Fever, lymphadenopathy, eosinophilia, lymphocytosis, hepatitis, and dermatitis: a severe adverse reaction to minocycline. J Am Acad Dermatol 1997; 36 (2 Pt 2): 347-50. PMID: 9039216
reference
Order 183
Style Reference-annotation
word/document.xml:/w:document[1]/w:body[1]/w:p[174]
(17 year old girl developed fever, lymphadenopathy, severe rash and mild hepatitis 3 weeks after starting minocycline for acne [bilirubin 2.3 mg/dL, ALT 134 U/L, Alk P 309 U/L, ANA negative] required corticosteroid therapy, but ultimately resolved).
reference
Order 184
Style Suggestedreading
word/document.xml:/w:document[1]/w:body[1]/w:p[175]
Herzog D, Hajoui O, Russo P, Alvarez F. Study of immune reactivity of minocycline-induced chronic active hepatitis. Dig Dis Sci 1997; 42: 1100-3. PMID: 9149070
reference
Order 185
Style Reference-annotation
word/document.xml:/w:document[1]/w:body[1]/w:p[176]
(16 year old girl developed arthralgias and anicteric hepatitis after 18 months of therapy with minocycline for acne [bilirubin evidently normal, ALT 392 U/L, Alk P normal, ANA 1:1280], resolved upon stopping; found serum antibodies to 90 kD and 50 kD fractions of HepG2 cells, possibly P-450 proteins).
reference
Order 186
Style Suggestedreading
word/document.xml:/w:document[1]/w:body[1]/w:p[177]
Björnsson E, Lindberg J, Olsson R. Liver reactions to oral low-dose tetracyclines. Scand J Gastroenterol 1997; 32: 390-5. Review. PMID: 9140164
reference
Order 187
Style Reference-annotation
word/document.xml:/w:document[1]/w:body[1]/w:p[178]
(32 year old man developed abdominal pain, dark urine and rash within 24 hours of starting doxycycline which he had received in the past [bilirubin 4.3- 8.1 mg/dL, ALT 3.5 times ULN, Alk P 1.1 times ULN], resolving within 3 months of stopping; thorough review of all published and SADRAC reported cases of oral tetracycline associated liver injury found 15 cases, only 6 rated as likely, none with tetracycline, 5 doxycycline, 1 lymecycline).
reference
Order 188
Style Suggestedreading
word/document.xml:/w:document[1]/w:body[1]/w:p[179]
Bruguera M, Padrós J. [Acute hepatitis associated with treatment with minocycline] Med Clin (Barc). 1997; 108: 596. PMID: 9280793
reference
Order 189
Style Reference-annotation
word/document.xml:/w:document[1]/w:body[1]/w:p[180]
(18 year old woman found to have enzyme elevations without symptoms or jaundice 1 month after starting minocycline [bilirubin normal, ALT 283, Alk P normal, ANA negative], resolving within 2-3 months of stopping).
reference
Order 190
Style Suggestedreading
word/document.xml:/w:document[1]/w:body[1]/w:p[181]
Crosson J, Stillman MT. Minocycline-related lupus erythematosus with associated liver disease. J Am Acad Dermatol 1997; 36 (5 Pt 2): 867-8. PMID: 9146570
reference
Order 191
Style Reference-annotation
word/document.xml:/w:document[1]/w:body[1]/w:p[182]
(22 year old woman developed arthralgias 2 years after starting minocycline therapy for acne [bilirubin 0.9 mgdL, ALT 292 U/L, Alk P 64 U/L, ANA 1:80], symptoms resolving rapidly upon stopping, but recurring abruptly after a single tablet, and serum ALT remained elevated for another 2 months before resolving).
reference
Order 192
Style Suggestedreading
word/document.xml:/w:document[1]/w:body[1]/w:p[183]
Golstein PE, Deviere J, Cremer M. Acute hepatitis and drug-related lupus induced by minocycline treatment. Am J Gastroenterol 1997; 92: 143-6. PMID: 8995955
reference
Order 193
Style Reference-annotation
word/document.xml:/w:document[1]/w:body[1]/w:p[184]
(19 year old man developed fatigue, weight loss, arthralgias and liver test abnormalities after 20 months of therapy with minocycline for acne [bilirubin normal, ALT 374 U/L, Alk P normal, ANA 1:640, IgG 2280 mg/dL], resolving upon stopping, but ANA persisted in high titer [1:1280 9 months later]).
reference
Order 194
Style Suggestedreading
word/document.xml:/w:document[1]/w:body[1]/w:p[185]
Hoefnagel JJ, van Leeuwen RL, Mattie H, Bastiaens MT. [Side effects of minocycline in the treatment of acne vulgaris] Ned Tijdschr Geneeskd 1997; 141: 1424-7. Dutch. PMID: 9542866
reference
Order 195
Style Reference-annotation
word/document.xml:/w:document[1]/w:body[1]/w:p[186]
(Editorial on association of minocycline with lupus, autoimmune hepatitis, vasculitis and serum sickness-like syndromes).
reference
Order 196
Style Suggestedreading
word/document.xml:/w:document[1]/w:body[1]/w:p[187]
Shapiro LE, Knowles SR, Shear NH. Comparative safety of tetracycline, minocycline, and doxycycline. Arch Dermatol 1997; 133: 1224-30. PMID: 9382560
reference
Order 197
Style Reference-annotation
word/document.xml:/w:document[1]/w:body[1]/w:p[188]
(Review of toxicity of tetracyclines from literature and a Canadian database; minocycline had the highest rates of adverse events, but all were relatively safe: no lupus-like syndrome associated with doxycycline or tetracycline).
reference
Order 198
Style Suggestedreading
word/document.xml:/w:document[1]/w:body[1]/w:p[189]
Angulo JM, Sigal LH, Espinoza LR. Coexistent minocycline-induced systemic lupus erythematosus and autoimmune hepatitis. Semin Arthritis Rheum 1998; 28: 187-92. PMID: 9872479
reference
Order 199
Style Reference-annotation
word/document.xml:/w:document[1]/w:body[1]/w:p[190]
(22 year old woman with arthralgias and jaundice after 1 year of minocycline therapy for acne [bilirubin 3.2 mg/dL, ALT 916 U/L, Alk P 204 U/L, ANA 1:640], resolving upon stopping, but arthralgias required prednisone for 18 months).
reference
Order 200
Style Suggestedreading
word/document.xml:/w:document[1]/w:body[1]/w:p[191]
Bhat G, Jordan J Jr, Sokalski S, Bajaj V, Marshall R, Berkelhammer C. Minocycline-induced hepatitis with autoimmune features and neutropenia. J Clin Gastroenterol 1998; 27: 74-5. PMID: 9706776
reference
Order 201
Style Reference-annotation
word/document.xml:/w:document[1]/w:body[1]/w:p[192]
(18 year old man developed hepatitis after 2 years of intermittent therapy with minocycline [bilirubin 4.8 mg/dL, ALT 1270 U/L, Alk P 117 U/L, ANA 1:1280], rapid response to prednisone and no relapse when stopped).
reference
Order 202
Style Suggestedreading
word/document.xml:/w:document[1]/w:body[1]/w:p[193]
Matteson EL, Johnson BW, Maher JD. Arthralgias, myalgias, and autoimmune hepatitis with minocycline therapy. J Rheumatol 1998; 25: 1653-4. PMID: 9712119
reference
Order 203
Style Reference-annotation
word/document.xml:/w:document[1]/w:body[1]/w:p[194]
(20 year old man developed fever and arthralgias after taking minocycline for 5 years for acne [no mention of bilirubin or jaundice, ALT 307 U/L, ANA 1:5280], full recovery 4 weeks after stopping).
reference
Order 204
Style Suggestedreading
word/document.xml:/w:document[1]/w:body[1]/w:p[195]
Pavese P, Sarrot-Reynauld F, Bonadona A, Massot C. [Immunoallergic reaction with hepatitis induced by minocycline] Ann Med Interne (Paris) 1998; 149: 521-3. French. PMID: 10021906
reference
Order 205
Style Reference-annotation
word/document.xml:/w:document[1]/w:body[1]/w:p[196]
(19 year old woman developed lupus-like syndrome and hepatitis after 2 years of minocycline therapy, resolving within 2 months of stopping).
reference
Order 206
Style Suggestedreading
word/document.xml:/w:document[1]/w:body[1]/w:p[197]
Teitelbaum JE, Perez-Atayde AR, Cohen M, Bousvaros A, Jonas MM. Minocycline-related autoimmune hepatitis: case series and literature review. Arch Pediatr Adolesc Med 1998; 152: 1132-6. PMID: 9811293
reference
Order 207
Style Reference-annotation
word/document.xml:/w:document[1]/w:body[1]/w:p[198]
(Three case reports of chronic autoimmune-like hepatitis in 15-16 year olds, arising 1-1.5 years after starting minocycline for acne [bilirubin normal to 26 mg/dL, ALT 363, 988 and 904 U/L, Alk P normal, all with ANA and high IgG], resolving in 2 to 9 months, 2 treated with prednisone; literature review).
reference
Order 208
Style Suggestedreading
word/document.xml:/w:document[1]/w:body[1]/w:p[199]
Angulo JM, Sigal LH, Espinoza LR. Minocycline induced lupus and autoimmune hepatitis. J Rheumatol 1999; 26: 1420-1. PMID: 10381074
reference
Order 209
Style Reference-annotation
word/document.xml:/w:document[1]/w:body[1]/w:p[200]
(22 year old woman had sudden onset of arthralgias and then jaundice after a year of minocycline for acne [bilirubin 3.2 mg/dL, ALT 916 U/L, Alk P 204 U/L, ANA 1:2560], biopsy showing chronic hepatitis, resolving rapidly upon stopping, but arthralgias required long term prednisone).
reference
Order 210
Style Suggestedreading
word/document.xml:/w:document[1]/w:body[1]/w:p[201]
Dadamessi I, Leduc I, Duché A, et al. [Autoimmune hepatitis and lupus syndrome associated with minocycline] Rev Med Interne 1999; 20: 930-3. French. PMID: 10573731
reference
Order 211
Style Reference-annotation
word/document.xml:/w:document[1]/w:body[1]/w:p[202]
(25 year old woman had two episodes of ALT elevations [peak 266 and 256 U/L, ANA 1:140 and 1:320] arising during minocycline therapy [first asymptomatic, second with arthralgias], resolving each time with discontinuation).
reference
Order 212
Style Suggestedreading
word/document.xml:/w:document[1]/w:body[1]/w:p[203]
Elkayam O, Yaron M, Caspi D. Minocycline-induced autoimmune syndromes: an overview. Semin Arthritis Rheum 1999; 28: 392-7. PMID: 10406406
reference
Order 213
Style Reference-annotation
word/document.xml:/w:document[1]/w:body[1]/w:p[204]
(Systematic review of literature on autoimmune syndromes from minocycline, 4 patterns: serum sickness, lupus-like syndrome, autoimmune hepatitis and vasculitis; usually presenting after 1-20 years, ANA common but so is pANCA, features may overlap, hepatitis most common: 66 cases reported).
reference
Order 214
Style Suggestedreading
word/document.xml:/w:document[1]/w:body[1]/w:p[205]
Westermann GW, Böhm M, Bonsmann G, Rahn KH, Kisters K. Chronic intoxication by doxycycline use for more than 12 years. J Intern Med 1999; 246: 591-2. PMID: 10620103
reference
Order 215
Style Reference-annotation
word/document.xml:/w:document[1]/w:body[1]/w:p[206]
(38 year old man took large doses of doxycycline chronically and developed repeated bouts of mild jaundice [bilirubin 3.4-5.0 mg/dL, ALT 44-118 U/L, Alk P 466 U/L] and weakness, skin discoloration and heart block, resolving upon stopping).
reference
Order 216
Style Suggestedreading
word/document.xml:/w:document[1]/w:body[1]/w:p[207]
Sturkenboom MC, Meier CR, Jick H, Stricker BH. Minocycline and lupuslike syndrome in acne patients. Arch Intern Med 1999; 159: 493-7. PMID: 10074958
reference
Order 217
Style Reference-annotation
word/document.xml:/w:document[1]/w:body[1]/w:p[208]
(Case control study in 27,688 acne patients in UK database, risk of lupus increased 8.5 fold in minocycline treated patients, not with other tetracyclines, typically long term therapy; liver involvement not mentioned; more common in women, absolute risk low).
reference
Order 218
Style Suggestedreading
word/document.xml:/w:document[1]/w:body[1]/w:p[209]
Colmegna I, Perandones CE, Chaves JG. Minocycline induced lupus and autoimmune hepatitis. J Rheumatol 2000; 27: 1567-8. PMID: 10852297
reference
Order 219
Style Reference-annotation
word/document.xml:/w:document[1]/w:body[1]/w:p[210]
(22 year old woman developed fever and polyarthralgias after 40 days of 9th course of minocycline for acne [bilirubin 4.9 mg/dL, ALT 1300 U/L and ESR 100], resolving rapidly but with prolonged rheumatological complaints requiring prednisone long term: ANA negative).
reference
Order 220
Style Suggestedreading
word/document.xml:/w:document[1]/w:body[1]/w:p[211]
Goldstein NS, Bayati N, Silverman AL, Gordon SC. Minocycline as a cause of drug-induced autoimmune hepatitis. Report of four cases and comparison with autoimmune hepatitis. Am J Clin Pathol 2000; 114: 591-8. PMID: 11026106
reference
Order 221
Style Reference-annotation
word/document.xml:/w:document[1]/w:body[1]/w:p[212]
(Four cases of minocycline hepatitis and comparison to 10 spontaneous autoimmune hepatitis cases showed no distinguishing features except resolution with stopping drug; 16-52 year old women developed liver injury 4 months to 12 years after starting minocycline [bilirubin 0.4, 1.2, 6.5 and 7.3 mg/dL, ALT 137, 343, 700, and 1288 U/L, Alk P 49, 83, 138 and 253 U/L, all ANA positive], histology showed fibrosis in 2, all responded to prednisone with resolution persisting after stopping corticosteroids).
reference
Order 222
Style Suggestedreading
word/document.xml:/w:document[1]/w:body[1]/w:p[213]
Lawrenson RA, Seaman HE, Sundström A, Williams TJ, Farmer RD. Liver damage associated with minocycline use in acne: a systematic review of the published literature and pharmacovigilance data. Drug Saf 2000; 23: 333-49. PMID: 11051220
reference
Order 223
Style Reference-annotation
word/document.xml:/w:document[1]/w:body[1]/w:p[214]
(Systematic review of cases of liver injury from minocycline in patients with acne defining two patterns – acute and chronic with different latencies, associated findings and potential outcomes).
reference
Order 224
Style Suggestedreading
word/document.xml:/w:document[1]/w:body[1]/w:p[215]
Pohle T, Menzel J, Domschke W. Minocycline and fulminant hepatic failure necessitating liver transplantation. Am J Gastroenterol 2000; 95: 560-1. PMID: 10685779
reference
Order 225
Style Reference-annotation
word/document.xml:/w:document[1]/w:body[1]/w:p[216]
(20 year old woman given minocycline for 3 years for acne developed autoimmune hepatitis but did not stop minocycline and progressed to hepatic failure and need for transplant 2 months later [bilirubin 11.7 rising to 25.4 mg/dL, ALT 199 U/L, GGT 34 U/L, ANA positive, IgG 2220 mg/dL]).
reference
Order 226
Style Suggestedreading
word/document.xml:/w:document[1]/w:body[1]/w:p[217]
Tomer G, Shneider BL. Minocycline-induced hepatitis. J Pediatr Gastroenterol Nutr 2000; 30: 105-6. PMID: 10630451
reference
Order 227
Style Reference-annotation
word/document.xml:/w:document[1]/w:body[1]/w:p[218]
(Editorial on minocycline and liver injury in children).
reference
Order 228
Style Suggestedreading
word/document.xml:/w:document[1]/w:body[1]/w:p[219]
Bachmeyer C, Cadranel JF. Minocycline-induced lupus and autoimmune hepatitis: family autoimmune disorders as possible risk factors. Dermatology 2002; 205: 185-6. PMID: 12218241
reference
Order 229
Style Reference-annotation
word/document.xml:/w:document[1]/w:body[1]/w:p[220]
(15 year old girl treated for 3 years with minocycline for acne developed polyarthritis, but no jaundice [bilirubin normal, ALT 4 times ULN, Alk P normal, anti-DNA positive, ANA 1:1280], resolving slowly upon stopping with all tests normal at 6 months, except ANA which was still 1:320 12 months later).
reference
Order 230
Style Suggestedreading
word/document.xml:/w:document[1]/w:body[1]/w:p[221]
Abe M, Furukawa S, Takayama S, Michitaka K, Minami H, Yamamoto, Horiike N, et al. Drug-induced hepatitis with autoimmune features during minocycline therapy. Intern Med 2003; 42: 48-52. PMID: 12583618
reference
Order 231
Style Reference-annotation
word/document.xml:/w:document[1]/w:body[1]/w:p[222]
(25 year old Japanese woman developed jaundice after 1 year of minocycline therapy for acne [bilirubin 23.7 mg/dL, ALT 2074 U/L, Alk P 138 U/L, IgG 2110 mg/dL, ANA 1:160], resolving with 3 month course of prednisone, no relapse with stopping).
reference
Order 232
Style Suggestedreading
word/document.xml:/w:document[1]/w:body[1]/w:p[223]
Real Martínez Y, Medina S. [Acute hepatitis and minocycline] Rev Esp Enferm Dig 2003; 95: 741-2. Spanish. PMID: 14588070
reference
Order 233
Style Reference-annotation
word/document.xml:/w:document[1]/w:body[1]/w:p[224]
(14 year old boy developed jaundice after 5 months of minocycline therapy for acne [bilirubin 5.1 mg/dL, ALT 2376 U/L, GGT 83 U/L, IgG 1734 mg/dL, ANA negative, SMA 1:320], treated with corticosteroids for 5 months and no relapse when stopped).
reference
Order 234
Style Suggestedreading
word/document.xml:/w:document[1]/w:body[1]/w:p[225]
Selimoglu MA, Ertekin V. Autoimmune hepatitis triggered by Brucella infection or doxycycline or both. Int J Clin Pract 2003; 57: 639-41. PMID: 14529072
reference
Order 235
Style Reference-annotation
word/document.xml:/w:document[1]/w:body[1]/w:p[226]
(11 year old girl was found to have abnormal liver tests 3 weeks after finishing a 6 week course of doxycycline for acute brucellosis [bilirubin 1.2 mg/dL, ALT 222 U/L, Alk P 561 U/L, ANA negative, HLA B8 DRB1*03], a liver biopsy showing inflammation, necrosis and bridging fibrosis, improving on prednisone therapy, relapsing on stopping and ultimately requiring long term azathioprine therapy).
reference
Order 236
Style Suggestedreading
word/document.xml:/w:document[1]/w:body[1]/w:p[227]
Russo MW, Galanko JA, Shrestha R, Fried MW, Watkins P. Liver transplantation for acute liver failure from drug-induced liver injury in the United States. Liver Transpl 2004; 10: 1018-23. PMID: 15390328
reference
Order 237
Style Reference-annotation
word/document.xml:/w:document[1]/w:body[1]/w:p[228]
(Among ~50,000 liver transplants done in the US between 1990 and 2002, 270 [0.5%] were done for drug induced acute liver failure, none of which were attributed to minocycline, doxycycline or tetracycline).
reference
Order 238
Style Suggestedreading
word/document.xml:/w:document[1]/w:body[1]/w:p[229]
Björnsson E, Jerlstad P, Bergqvist A, Olsson R. Fulminant drug-induced hepatic failure leading to death or liver transplantation in Sweden. Scand J Gastroenterol 2005; 40: 1095-1101. PMID: 16165719
reference
Order 239
Style Reference-annotation
word/document.xml:/w:document[1]/w:body[1]/w:p[230]
(Among 103 cases of fulminant drug induced liver injury reported to a Swedish registry between 1966 and 2002, one case was attributed to doxycycline, but no other tetracycline mentioned).
reference
Order 240
Style Suggestedreading
word/document.xml:/w:document[1]/w:body[1]/w:p[231]
Andrade RJ, Lucena MI, Fernández MC, Pelaez G, Pachkoria K, Garcia-Ruiz E, Garcia-Munoz B, et al. Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish Registry over a 10-year period. Gastroenterology 2005; 129: 512-21. PMID: 16083708
reference
Order 241
Style Reference-annotation
word/document.xml:/w:document[1]/w:body[1]/w:p[232]
(Reports to a Spanish network found 461 cases of drug induced liver disease; no tetracycline was listed among the top 20 agents implicated [at least 5 cases]).
reference
Order 242
Style Suggestedreading
word/document.xml:/w:document[1]/w:body[1]/w:p[233]
Smith K, Leyden JJ. Safety of doxycycline and minocycline: a systematic review. Clin Ther 2005; 27: 1329-42. PMID: 16291409
reference
Order 243
Style Reference-annotation
word/document.xml:/w:document[1]/w:body[1]/w:p[234]
(Systematic review of overall safety of doxycycline and minocycline stressing overall low rate of adverse events [13-72 per million prescriptions]; little mention of liver toxicity).
reference
Order 244
Style Suggestedreading
word/document.xml:/w:document[1]/w:body[1]/w:p[235]
Galan MV, Potts JA, Silverman AL, Gordon SC. The burden of acute nonfulminant drug-induced hepatitis in a United States tertiary referral center. J Clin Gastroenterol 2005; 39: 64-7. PMID: 15599214
reference
Order 245
Style Reference-annotation
word/document.xml:/w:document[1]/w:body[1]/w:p[236]
(Ten year experience of 96 patients with acute liver injury, 64 were due to viral hepatitis and 32 to drugs; minocycline accounted for 4 cases and ranked second in frequency [7 from amiodarone and 4 from amoxicillin/clavulanate]).
reference
Order 246
Style Suggestedreading
word/document.xml:/w:document[1]/w:body[1]/w:p[237]
Chamberlain MC, Schwarzenberg SJ, Akin EU, Kurth MH. Minocycline-induced autoimmune hepatitis with subsequent cirrhosis. J Pediatr Gastroenterol Nutr 2006; 42: 232-5. PMID: 16456421
reference
Order 247
Style Reference-annotation
word/document.xml:/w:document[1]/w:body[1]/w:p[238]
(15 year old boy developed signs of cirrhosis after 1 year of minocycline therapy [bilirubin 2.5 mg/dL, ALT 67-83 U/L, Alk P normal, ANA 1:40, anti-DNA positive], treated with 6-mercaptopurine and prednisone with only partial response and found to have cirrhosis on follow up liver biopsy).
reference
Order 248
Style Suggestedreading
word/document.xml:/w:document[1]/w:body[1]/w:p[239]
Björnsson E, Olsson R. Suspected drug-induced liver fatalities reported to the WHO database. Dig Liver Dis 2006; 38: 33-8. PMID: 16054882
reference
Order 249
Style Reference-annotation
word/document.xml:/w:document[1]/w:body[1]/w:p[240]
(Survey of drug induced liver fatalities reported to WHO database between 1968-2003 revealed 4690 reports – 89% from the US; the list of most 21 most commonly implicated drugs did not include a tetracycline).
reference
Order 250
Style Suggestedreading
word/document.xml:/w:document[1]/w:body[1]/w:p[241]
Basude D, Dhawan A. Re: Minocycline-induced autoimmune hepatitis with subsequent cirrhosis. J Pediatr Gastroenterol Nutr 2007; 44: 389; author reply 389-90. PMID: 17325565
reference
Order 251
Style Reference-annotation
word/document.xml:/w:document[1]/w:body[1]/w:p[242]
(Letter in response to Chamberlain [2006] arguing that the child likely had a preexisting cryptogenic cirrhosis not related to minocycline therapy).
reference
Order 252
Style Suggestedreading
word/document.xml:/w:document[1]/w:body[1]/w:p[243]
Margolis DJ, Hoffstad O, Bilker W. Association or lack of association between tetracycline class antibiotics used for acne vulgaris and lupus erythematosus. Br J Dermatol 2007; 157: 540-6. PMID: 17596147
reference
Order 253
Style Reference-annotation
word/document.xml:/w:document[1]/w:body[1]/w:p[244]
(Analysis of UK database on 97,694 subjects with acne, 25% received minocycline, 16% doxycycline and 45% other tetracyclines. Hazard ratio for lupus-like syndrome was 3.11 for minocycline; no increased risk or association with doxycycline or other tetracyclines).
reference
Order 254
Style Suggestedreading
word/document.xml:/w:document[1]/w:body[1]/w:p[245]
Egiguren L, Minondo L, Zapata E, Castiella A. [Patient with autoimmune hepatitis and idiopathic thrombocytopenic purpura after minocycline therapy] Gastroenterol Hepatol 2007; 30: 565-6. Spanish. PMID: 17980139
reference
Order 255
Style Reference-annotation
word/document.xml:/w:document[1]/w:body[1]/w:p[246]
(15 year old girl developed jaundice 1 month after starting minocycline therapy for acne [bilirubin 4.4 mg/dL, ALT 1232 U/L, Alk P 555 U/L, ANA 1:1280], developing idiopathic thrombocytopenic purpura when treated with prednisone; no follow up available).
reference
Order 256
Style Suggestedreading
word/document.xml:/w:document[1]/w:body[1]/w:p[247]
Losanoff JE, Holder-Murray JM, Ahmed EB, Cochrane AB, Testa G, Millis JM. Minocycline toxicity requiring liver transplant. Dig Dis Sci 2007; 52: 3242-4. PMID: 17404879
reference
Order 257
Style Reference-annotation
word/document.xml:/w:document[1]/w:body[1]/w:p[248]
(33 year old woman developed jaundice 7 weeks after starting minocycline for acne [bilirubin 9.9 mg/dL, ALT 882 U/L, Alk P 191 U/L, ANA positivity], with subsequent worsening despite stopping drug, ultimately requiring liver transplantation; graft showed massive necrosis).
reference
Order 258
Style Suggestedreading
word/document.xml:/w:document[1]/w:body[1]/w:p[249]
Heaton PC, Fenwick SR, Brewer DE. Association between tetracycline or doxycycline and hepatotoxicity: a population based case-control study. J Clin Pharm Ther 2007; 32: 483-7. PMID: 17875115
reference
Order 259
Style Reference-annotation
word/document.xml:/w:document[1]/w:body[1]/w:p[250]
(Analysis of 2 years of Medicaid claims in California found 3377 cases of “hepatotoxicity”; 20 had received tetracycline <45 days before onset; only 4 controls had: adjusted odds ratio 3.7; not elevated for doxycycline; this despite safety record of oral tetracyclines and known hepatotoxicity of doxycycline).
reference
Order 260
Style Suggestedreading
word/document.xml:/w:document[1]/w:body[1]/w:p[251]
Ford TJ, Dillon JF. Minocycline hepatitis. Eur J Gastroenterol Hepatol 2008; 20: 796-9. PMID: 18617786
reference
Order 261
Style Reference-annotation
word/document.xml:/w:document[1]/w:body[1]/w:p[252]
(20 year old developed fatigue and jaundice 1 year after starting minocycline for acne [bilirubin 5.0 mg/dL, AST 1095 U/L, Alk P 178 U/L, ANA 1: 2560], resolving within 1-2 months of stopping accompanied by fall in ANA titers to normal).
reference
Order 262
Style Suggestedreading
word/document.xml:/w:document[1]/w:body[1]/w:p[253]
Meropol SB, Chan KA, Chen Z, Finkelstein JA, Hennessy S, Lautenbach E, Platt R, et al. Adverse events associated with prolonged antibiotic use. Pharmacoepidemiol Drug Saf 2008 17: 423-32. PMID: 18215001
reference
Order 263
Style Reference-annotation
word/document.xml:/w:document[1]/w:body[1]/w:p[254]
(Analysis of 3 large UK and US databases on medication use and clinical outcomes covering ~6 million patients for adverse events related to >1 month of either amoxicillin [0-1.2/100,000], ciprofloxacin [0-5.7/100,000] and doxycycline [0-0.9/100,000 person days], but no mention of liver toxicities).
reference
Order 264
Style Suggestedreading
word/document.xml:/w:document[1]/w:body[1]/w:p[255]
Carrascosa MF, Lucena MI, Andrade RJ, Caviedes JRS, et al. Fatal acute hepatitis after sequential treatment with levofloxacin, doxycycline, and naproxen in a patient presenting with acute Mycoplasma pneumoniae infection. Clin Ther 2009; 31: 1014-19. PMID: 19539102
reference
Order 265
Style Reference-annotation
word/document.xml:/w:document[1]/w:body[1]/w:p[256]
(63 year old man developed acute liver injury 1 week after starting a 3 day course of levofloxacin and 5 days after starting doxycycline [bilirubin 4.0 rising to >35 mg/dL, ALT 1577 U/L, Alk P 189 U/L], with subsequent progressive liver failure and death; biopsy showed massive necrosis).
reference
Order 266
Style Suggestedreading
word/document.xml:/w:document[1]/w:body[1]/w:p[257]
Chalasani N, Fontana RJ, Bonkovsky HL, Watkins PB, Davern T, Serrano J, Yang H, Rochon J; Drug Induced Liver Injury Network (DILIN). Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States. Gastroenterology 2008; 135: 1924-34. PMID: 18955056
reference
Order 267
Style Reference-annotation
word/document.xml:/w:document[1]/w:body[1]/w:p[258]
(Among 300 cases of drug induced liver disease in the US collected from 2004 to 2008, minocycline accounted for 3 cases, doxycycline for 3 cases and tetracycline was listed as a secondary possible cause for one).
reference
Order 268
Style Suggestedreading
word/document.xml:/w:document[1]/w:body[1]/w:p[259]
Chavant F, Lafay-Chebassier C, Beauchant M, Perault-Pochat MC. [Doxycycline induced hepatitis]. Gastroenterol Clin Biol 2008; 32: 825-7. French. PMID: 18823729
reference
Order 269
Style Reference-annotation
word/document.xml:/w:document[1]/w:body[1]/w:p[260]
(37 year old man developed fatigue 6 weeks after starting doxycycline [bilirubin 2.8 mg/dL, ALT 2322 U/L, Alk P 184 U/L, ANA 1:100], resolving within 6 weeks of stopping).
reference
Order 270
Style Suggestedreading
word/document.xml:/w:document[1]/w:body[1]/w:p[261]
Robles DT, Leonard JL, Compton N, Waghmare A, McDonough KA, George E, Wolgamot G, Fleckman P. Severe drug hypersensitivity reaction in a young woman treated with doxycycline. Dermatology 2008; 217: 23-6. PMID: 18332631
reference
Order 271
Style Reference-annotation
word/document.xml:/w:document[1]/w:body[1]/w:p[262]
(20 year old woman developed severe rash and fever 3 weeks after starting doxycycline for acne [bilirubin 2.5 mg/dL, ALT 133 U/L, Alk P 205 U/L, eosinophils 980/µL], requiring intubation and corticosteroid therapy and 3 week hospitalization, ultimately resolving).
reference
Order 272
Style Suggestedreading
word/document.xml:/w:document[1]/w:body[1]/w:p[263]
Maubec E, Wolkenstein P, Loriot MA, Wechsler J, Mulot C, Beaune P, Revuz J, Roujeau JC. Minocycline-induced DRESS: evidence for accumulation of the culprit drug. Dermatology 2008; 216: 200-4. PMID: 18182810
reference
Order 273
Style Reference-annotation
word/document.xml:/w:document[1]/w:body[1]/w:p[264]
(Review of 9 patients with DRESS syndrome due to minocycline; 8 women and 1 man, ages 15-45, onset after 16 to 60 days, 8 with liver “dysfunction”, resolving after 1 to 8 months, but two died, not of liver disease).
reference
Order 274
Style Suggestedreading
word/document.xml:/w:document[1]/w:body[1]/w:p[265]
Ramakrishna J, Johnson AR, Banner BF. Long-term minocycline use for acne in healthy adolescents can cause severe autoimmune hepatitis. J Clin Gastroenterol 2009; 43: 787-90. PMID: 19262406
reference
Order 275
Style Reference-annotation
word/document.xml:/w:document[1]/w:body[1]/w:p[266]
(Three cases of minocycline hepatotoxicity; 16 year olds with onset of jaundice 2, 13 and 24 months after starting minocycline for acne [bilirubin 19.6, 9.1 and 9.5 mg/dL, ALT 1282, 2306 and 2056 U/L, ANA 1:160-1:640], liver biopsies showing hepatitis and fibrosis; all treated with corticosteroids, 2 requiring prolonged therapy).
reference
Order 276
Style Suggestedreading
word/document.xml:/w:document[1]/w:body[1]/w:p[267]
Ferrajolo C, Capuano A, Verhamme KM, Schuemie M, Rossi F, Stricker BH, Sturkenboom MC. Drug-induced hepatic injury in children: a case/non-case study of suspected adverse drug reactions in VigiBase. Br J Clin Pharmacol 2010; 70: 721-8. PMID: 21039766
reference
Order 277
Style Reference-annotation
word/document.xml:/w:document[1]/w:body[1]/w:p[268]
(Worldwide pharmacovigilance database containing 9036 hepatic adverse drug reactions in children includes 117 cases attributed to minocycline, but no other tetracycline listed in the top 40 causes).
reference
Order 278
Style Suggestedreading
word/document.xml:/w:document[1]/w:body[1]/w:p[269]
Devarbhavi H, Dierkhising R, Kremers WK, Sandeep MS, Karanth D, Adarsh CK. Single-center experience with drug-induced liver injury from India: causes, outcome, prognosis, and predictors of mortality. Am J Gastroenterol 2010; 105: 2396-404. PMID: 20648003
reference
Order 279
Style Reference-annotation
word/document.xml:/w:document[1]/w:body[1]/w:p[270]
(313 cases of drug induced liver injury were seen over a 12 year period at a large hospital in Bangalore, India; none were due to tetracyclines).
reference
Order 280
Style Suggestedreading
word/document.xml:/w:document[1]/w:body[1]/w:p[271]
Reuben A, Koch DG, Lee WM; Acute Liver Failure Study Group. Drug-induced acute liver failure: results of a U.S. multicenter, prospective study. Hepatology 2010; 52: 2065-76. PMID: 20949552
reference
Order 281
Style Reference-annotation
word/document.xml:/w:document[1]/w:body[1]/w:p[272]
(Among 1198 patients with acute liver failure enrolled in a US prospective study between 1998 and 2007, 133 were attributed to drug induced liver injury and 25 to antituberculosis agents, including 15 to isoniazid alone [ranking first], 6 to isoniazid combined with other agents, 3 to rifampin and pyrazinamide, and 1 to dapsone).
reference
Order 282
Style Suggestedreading
word/document.xml:/w:document[1]/w:body[1]/w:p[273]
Björnsson E, Talwalkar J, Treeprasertsuk S, Kamath PS, Takahashi N, Sanderson S, Neuhauser M, Lindor K. Drug-induced autoimmune hepatitis: clinical characteristics and prognosis. Hepatology 2010; 51: 2040-8. PMID: 20512992
reference
Order 283
Style Reference-annotation
word/document.xml:/w:document[1]/w:body[1]/w:p[274]
(Among 261 cases of autoimmune hepatitis seen at the Mayo Clinic between 1997 and 2007, 24 were attributed to drugs, 11 to minocycline, 11 to nitrofurantoin and 2 to others; all responded to corticosteroid therapy and all who were withdrawn did not relapse).
reference
Order 284
Style Suggestedreading
word/document.xml:/w:document[1]/w:body[1]/w:p[275]
Casella G, Villanacci V, Di Bella C, Drera E, Baldini V, Bassotti G. Acute hepatitis caused by minocycline. Rev Esp Enferm Dig 2010; 102: 668. PMID: 21142391
reference
Order 285
Style Reference-annotation
word/document.xml:/w:document[1]/w:body[1]/w:p[276]
(80 year old woman was found to have enzyme elevations after a year of minocycline therapy [bilirubin 2.2 mg/dL, ALT 721 U/L, GGT 107 U/L, ANA 1:320, INR 1.2], responding to corticosteroid therapy, and enzymes remained normal after their discontinuation).
reference
Order 286
Style Suggestedreading
word/document.xml:/w:document[1]/w:body[1]/w:p[277]
Mailhol C, Tremeau-Martinage C, Paul C, Godel A, Lamant L, Giordano-Labadie F. [Severe drug hypersensitivity reaction (DRESS syndrome) to doxycycline]. Ann Dermatol Venereol 2010; 137: 40-3. French. PMID: 20110067
reference
Order 287
Style Reference-annotation
word/document.xml:/w:document[1]/w:body[1]/w:p[278]
(59 year old woman developed fever, rash and facial edema 3 weeks after starting doxycycline for malaria prophylaxis [bilirubin normal, ALT 278 U/L, eosinophils 15%, atypical lymphocytosis], resolving on discontinuation).
reference
Order 288
Style Suggestedreading
word/document.xml:/w:document[1]/w:body[1]/w:p[279]
Leitner JM, Graninger W, Thalhammer F. Hepatotoxicity of antibacterials: Pathomechanisms and clinical. Infection 2010; 38: 3-11. PMID: 20107858
reference
Order 289
Style Reference-annotation
word/document.xml:/w:document[1]/w:body[1]/w:p[280]
(Review of hepatotoxicity of antibiotics; mentions that hepatotoxicity from oral tetracycline is rare ~1.5 cases per million prescriptions, whereas minocycline has been associated with either an immediate reaction with eosinophilia, dermatitis and enzyme elevations or a delayed autoimmune hepatitis-like syndrome).
reference
Order 290
Style Suggestedreading
word/document.xml:/w:document[1]/w:body[1]/w:p[281]
Glenn C, Feldman SR. Letter: Tetracycline-induced hepatotoxicity. Dermatol Online J 2011; 17: 14. PMID: 22233750
reference
Order 291
Style Reference-annotation
word/document.xml:/w:document[1]/w:body[1]/w:p[282]
(49 year old woman developed fatigue, edema, low albumin and raised alkaline phosphatase levels [bilirubin and ALT normal] 6 months after starting oral tetracycline for rosacea, albumin and alkaline phosphatase levels returning to normal upon stopping, later tolerating doxycycline).
reference
Order 292
Style Suggestedreading
word/document.xml:/w:document[1]/w:body[1]/w:p[283]
Czaja AJ. Drug-induced autoimmune-like hepatitis. Dig Dis Sci 2011; 56: 958-76. PMID: 21327704
reference
Order 293
Style Reference-annotation
word/document.xml:/w:document[1]/w:body[1]/w:p[284]
(Review of drug induced autoimmune hepatitis-like syndromes, most commonly caused by nitrofurantoin and minocycline, but also with hydralazine, methyldopa and more rarely with statins, fibrates, NSAIDs, various herbals and tumor necrosis factor antagonists).
reference
Order 294
Style Suggestedreading
word/document.xml:/w:document[1]/w:body[1]/w:p[285]
Aldenhoven M, van Enk JG, Avis WA. [Minocycline-induced autoimmune hepatitis]. Ned Tijdschr Geneeskd 2013; 157: A5465. Dutch. PMID: 23328022
reference
Order 295
Style Reference-annotation
word/document.xml:/w:document[1]/w:body[1]/w:p[286]
(Abstract: 14 year old girl developed liver injury with positive ANA after long term use of minocycline, resolving after stopping the drug without corticosteroid therapy).
reference
Order 296
Style Suggestedreading
word/document.xml:/w:document[1]/w:body[1]/w:p[287]
Björnsson ES, Bergmann OM, Björnsson HK, Kvaran RB, Olafsson S. Incidence, presentation and outcomes in patients with drug-induced liver injury in the general population of Iceland. Gastroenterology 2013; 144: 1419-25. PMID: 23419359
reference
Order 297
Style Reference-annotation
word/document.xml:/w:document[1]/w:body[1]/w:p[288]
(In a population based study of drug induced liver injury from Iceland, 96 cases were identified over a 2 year period, 2 were attributed to doxycycline but none to minocycline).
reference
Order 298
Style Suggestedreading
word/document.xml:/w:document[1]/w:body[1]/w:p[289]
Hernández N, Bessone F, Sánchez A, di Pace M, Brahm J, Zapata R, A Chirino R, et al. Profile of idiosyncratic drug induced liver injury in Latin America. An analysis of published reports. Ann Hepatol 2014; 13: 231-9. PMID: 24552865
reference
Order 299
Style Reference-annotation
word/document.xml:/w:document[1]/w:body[1]/w:p[290]
(Systematic review of literature of drug induced liver injury in Latin American countries published from 1996 to 2012 identified 176 cases, 37 of which were attributed to an antibiotic, but none to a tetracycline).
reference
Order 300
Style Suggestedreading
word/document.xml:/w:document[1]/w:body[1]/w:p[291]
deLemos AS, Foureau DM, Jacobs C, Ahrens W, Russo MW, Bonkovsky HL. Drug-induced liver injury with autoimmune features. Semin Liver Dis 2014; 34: 194-204. PMID: 24879983
reference
Order 301
Style Reference-annotation
word/document.xml:/w:document[1]/w:body[1]/w:p[292]
(Review of drug induced autoimmune hepatitis with examples due to methyldopa, hydralazine, minocycline and nitrofurantoin).
reference
Order 302
Style Suggestedreading
word/document.xml:/w:document[1]/w:body[1]/w:p[293]
Douros A, Bronder E, Andersohn F, Klimpel A, Thomae M, Sarganas G, Kreutz R, et al. Drug-induced liver injury: results from the hospital-based Berlin Case-Control Surveillance Study. Br J Clin Pharmacol 2015; 79: 988-99. PMID: 25444550
reference
Order 303
Style Reference-annotation
word/document.xml:/w:document[1]/w:body[1]/w:p[294]
(Among 76 inpatients with hepatitis of unknown cause enrolled in a prospective case-cohort surveillance study between 2002 and 2011, one was attributed to doxycycline, but no other tetracycline was implicated).
reference
Order 304
Style Suggestedreading
word/document.xml:/w:document[1]/w:body[1]/w:p[295]
Chalasani N, Bonkovsky HL, Fontana R, Lee W, Stolz A, Talwalkar J, Reddy KR, et al.; United States Drug Induced Liver Injury Network. Features and outcomes of 899 patients with drug-induced liver injury: The DILIN Prospective Study. Gastroenterology 2015; 148: 1340-52.e7. PMID: 25754159
reference
Order 305
Style Reference-annotation
word/document.xml:/w:document[1]/w:body[1]/w:p[296]
(Among 899 cases of drug induced liver injury enrolled in a US prospective study between 2004 and 2013, 323 [36%] were attributed to antibiotics including 28 [3%] to minocycline and 4 [0.4%] to doxycycline).
reference
Order 306
Style Suggestedreading
word/document.xml:/w:document[1]/w:body[1]/w:p[297]
Urban TJ, Nicoletti P, Chalasani N, Serrano J, Stolz A, Daly AK, Aithal GP, et al; Drug-Induced Liver Injury Network (DILIN); Pharmacogenetics of Drug-Induced Liver Injury group (DILIGEN); International Serious Adverse Events Consortium (iSAEC). Minocycline hepatotoxicity: clinical characterization and identification of HLA-B∗35:02 as a risk factor. J Hepatol 2017; 67: 137-44. PMID: 28323125
reference
Order 307
Style Reference-annotation
word/document.xml:/w:document[1]/w:body[1]/w:p[298]
(The uncommon HLA allele B*35:02 was found in 4 of 25 [16%] of patients with minocycline hepatotoxicity vs 0.6% in a population control group; those with and without this allele did not different in clinical features or outcome).
reference
Order 308
Style Suggestedreading
word/document.xml:/w:document[1]/w:body[1]/w:p[299]
de Boer YS, Kosinski AS, Urban TJ, Zhao Z, Long N, Chalasani N, Kleiner DE, Hoofnagle JH; Drug-Induced Liver Injury Network. Features of autoimmune hepatitis in patients with drug-induced liver injury. Clin Gastroenterol Hepatol 2017; 15: 103-12. PMID: 27311619
reference
Order 309
Style Reference-annotation
word/document.xml:/w:document[1]/w:body[1]/w:p[300]
(Among 88 cases of drug induced liver injury, autoimmune features were found in 83% of nitrofurantoin, 74% of minocycline, 60% of methyldopa and 43% of hydralazine associated cases. ANA and SMA titers and IgG levels tended to fall with recovery, and cases with autoimmune features were similar clinically to those without except for a tendency for a longer latency to onset in those with autoantibodies).
reference
Order 310
Style Suggestedreading
word/document.xml:/w:document[1]/w:body[1]/w:p[301]
Harmon EG, McConnie R, Kesavan A. Minocycline-induced autoimmune hepatitis: a rare but important cause of drug-induced autoimmune hepatitis. Pediatr Gastroenterol Hepatol Nutr 2018; 21: 347-50. PMID: 30345250
reference
Order 311
Style Reference-annotation
word/document.xml:/w:document[1]/w:body[1]/w:p[302]
(17 year old male developed jaundice 5 months after starting minocycline [100 mg daily] for acne [bilirubin 10.2 rising to 21.8 mg/dL, ALT 2229 U/L, Alk P not given, ANA negative], biopsy showing autoimmune-like features leading to a 12 week course of prednisone and ultimate recovery).
reference
Order 312
Style Suggestedreading
word/document.xml:/w:document[1]/w:body[1]/w:p[303]
Shankar S, Oliver MR. Primum non nocere: minocycline-induced liver injury in a teenager. J Paediatr Child Health 2018; 54: 1031-3. PMID: 29962030
reference
Order 313
Style Reference-annotation
word/document.xml:/w:document[1]/w:body[1]/w:p[304]
(15 year old girl developed fever, rash, lymphadenopathy and abdominal pain 4 weeks after starting minocycline [100 mg daily] for acne [bilirubin normal, ALT 688 U/L, GGT 281 U/L, eosinophils 500/μL], treated with corticosteroids and had fully recovered when seen 6 months later).
reference
Order 314
Style Suggestedreading
word/document.xml:/w:document[1]/w:body[1]/w:p[305]
Shah J, Shahidullah A, Liu Y. Drug-induced autoimmune hepatitis in a patient treated with minocycline: a rare adverse effect. Case Rep Gastroenterol 2018; 12: 447-52. PMID: 30186098
reference
Order 315
Style Reference-annotation
word/document.xml:/w:document[1]/w:body[1]/w:p[306]
(31 year old woman developed nausea and abdominal pain 3 months after starting minocycline for acne [bilirubin 1.8 mg/dL, ALT 1138 U/L, Alk P 160 U/L, INR 1.9, ANA 1:160, IgG 3176 mg/dL], with a rapid response to prednisolone [given for 4 weeks] and ultimate complete recovery). PMID:
reference
Order 316
Style Suggestedreading
word/document.xml:/w:document[1]/w:body[1]/w:p[307]
Wei C, Liu Y, Jiang A, Wu B. A pharmacovigilance study of the association between tetracyclines and hepatotoxicity based on Food and Drug Administration adverse event reporting system data. Int J Clin Pharm. 2022;44:709-716. PMID: 35364753
reference
Order 317
Style Reference-annotation
word/document.xml:/w:document[1]/w:body[1]/w:p[308]
(Analysis of the spontaneous reports of drug-induced liver injury to the FDA adverse event reporting system [FAERS] made between 2004 and 2020 identified 1435 cases, most due to minocycline [n=547], doxycycline [545], and tigecycline [288] with increasing numbers in recent years).
reference
Order 318
Style Suggestedreading
word/document.xml:/w:document[1]/w:body[1]/w:p[309]
Nikolajevic N, Nikolajevic M, Pantic I, Korica B, Kotseva M, Alempijevic T, Jevtic D, et al. Drug-induced liver injury due to doxycycline: a case report and review of literature. Cureus. 2024;16:e59687. PMID: 38836151
reference
Order 319
Style Reference-annotation
word/document.xml:/w:document[1]/w:body[1]/w:p[310]
(28 year old man with Lyme disease developed nausea 5 days after starting doxycycline [100 mg twice daily] with bilirubin 0.7 mg/dL, ALT 758 U/L, Alk P normal, INR 1.1 and improvement on stopping doxycycline and switching to amoxicillin, with normal liver tests one month later).
reference
Order 320
Style Suggestedreading
word/document.xml:/w:document[1]/w:body[1]/w:p[311]
Torgersen J, Mezochow AK, Newcomb CW, Carbonari DM, Hennessy S, Rentsch CT, Park LS, et al. Severe acute liver injury after hepatotoxic medication initiation in real-world data. JAMA Intern Med. 2024;184:943-952. PMID: 38913369.
reference
Order 321
Style Reference-annotation
word/document.xml:/w:document[1]/w:body[1]/w:p[312]
(Analysis of the US Veterans Administration electronic health records between 1999 and 2021 identified 1739 hospitalizations for acute liver injury suspected to be due to medications including doxycycline at an estimate rate of 1 per 3,700 persons per year of exposure; no cases due to minocycline found).
reference
Order 322
Style Suggestedreading
word/document.xml:/w:document[1]/w:body[1]/w:p[313]
Bessone F, Hernandez N, Medina-Caliz I, García-Cortés M, Schinoni MI, Mendizabal M, Chiodi D, et al. Drug-induced liver injury in Latin America: 10-year experience of the Latin American DILI (LATINDILI) Network. Clin Gastroenterol Hepatol. 2025;23:89-102. PMID: 38992407.
reference
Order 323
Style Reference-annotation
word/document.xml:/w:document[1]/w:body[1]/w:p[314]
(Among 483 cases of drug-induced liver injury enrolled in a prospective Latin American database 4 [1%} were attributed to minocycline, but only one [0.2%] to doxycycline).
reference
Order 325
Style Suggestedreading
word/document.xml:/w:document[1]/w:body[1]/w:p[315]
Chen VL, Rockey DC, Bjornsson ES, Barnhart H, Hoofnagle JH; Drug-Induced Liver Injury Network Investigators. Incidence of idiosyncratic drug-induced liver Injury caused by prescription drugs. Drug Saf. 2025;48:151-160. 39317916.
reference
Order 326
Style Reference-annotation
word/document.xml:/w:document[1]/w:body[1]/w:p[316]
(Analysis of 1284 cases of drug-induced liver injury enrolled in a U.S. prospective study, identified 44 cases [3.4%] attributed to minocycline being the 6th most commonly implicated drug and occurring at an estimated rate of 1 per 1,100 persons treated).
reference
Order 328
Style Suggestedreading
word/document.xml:/w:document[1]/w:body[1]/w:p[317]
Weber S, Gerbes AL. Relapse and need for extended immunosuppression: novel features of drug-induced autoimmune hepatitis. Digestion. 2023;104(3):243-248. PMID: 36603570
reference
Order 329
Style Reference-annotation
word/document.xml:/w:document[1]/w:body[1]/w:p[318]
(Comparison of patients with autoimmune hepatitis [n=19], to autoimmune-like drug induced liver injury [n=11, 1 due to minocycline] found differences only in the need for long-term immunosuppression [27% vs 13%]).
reference
Order 330
Style Suggestedreading
word/document.xml:/w:document[1]/w:body[1]/w:p[319]
García-Cortés M, Ortega-Alonso A, Matilla-Cabello G, Medina-Cáliz I, Castiella A, Conde I, Bonilla-Toyos E, et al. Clinical presentation, causative drugs and outcome of patients with autoimmune features in two prospective DILI registries. Liver Int. 2023;43:1749-1760. PMID: 37269163
reference
Order 331
Style Reference-annotation
word/document.xml:/w:document[1]/w:body[1]/w:p[320]
(Among 1426 patients with enrolled in the Spanish and Latin American Drug Induced Liver Injury Registries, 33 had autoimmune-like liver injury, which were 58% females, 84% hepatocellular, typically with a long latency, 91% with ANA, 34% SMA, 12% severe and 3% fatal; 8 due to statins, 5 nitrofurantoin, 4 minocycline, only 1 an herbal product).
reference
Order 332
Style Suggestedreading
word/document.xml:/w:document[1]/w:body[1]/w:p[321]
Bessone F, Bjornsson ES. Autoimmune-like hepatitis induced by drugs: still many unanswered questions. World J Hepatol. 2025;17:110946. PMID: 4136810
reference
Order 333
Style Reference-annotation
word/document.xml:/w:document[1]/w:body[1]/w:p[322]
(Review of autoimmune-like drug induced liver injury and features that distinguish it from spontaneous, idiopathic autoimmune hepatitis, the major features being lack or minimal fibrosis and lack of relapse after resolution with or without corticosteroid therapy in drug-induced liver injury with autoimmune features that is common with chronic minocycline therapy in which relapse after corticosteroid-induced remission is very rare, but has been reported).
reference
Order 334
Style Suggestedreading
word/document.xml:/w:document[1]/w:body[1]/w:p[323]
Reinhart JM. Drug-induced liver injury. Vet Clin North Am Small Anim Pract. 2025;55:717-730. PMID: 40280782
reference
Order 335
Style Reference-annotation
word/document.xml:/w:document[1]/w:body[1]/w:p[324]
(Extensive review of drug-induced liver injury in veterinary animals mentions that 39% of dogs and 19% of cats develop ALT elevations on doxycycline therapy but that clinically apparent injury must be rare).
heading
Order 340
Level 2
Style Heading2
word/document.xml:/w:document[1]/w:body[1]/w:p[329]
H2. OTHER REFERENCE LINKS
paragraph
Order 341
Style Processinginstruction
word/document.xml:/w:document[1]/w:body[1]/w:p[330]
list
Order 342
word/document.xml:/w:document[1]/w:body[1]/w:p[331]
list
Order 343
word/document.xml:/w:document[1]/w:body[1]/w:p[332]
heading
Order 344
Level 2
Style FiguresTablesBoxesSectionHeading
word/document.xml:/w:document[1]/w:body[1]/w:p[333]
H2. [figs-and-tables] Figures, Tables and Boxes Appendix (do not delete)
paragraph
Order 345
Style Comment
word/document.xml:/w:document[1]/w:body[1]/w:p[334]
Place numbered figures, tables and boxes (referred to from the main text) below.
paragraph
Order 346
Style Comment
word/document.xml:/w:document[1]/w:body[1]/w:p[335]
“In-line” figures (e.g. equations) and tables should be placed within the main text in their desired final location.